View Filing Data

Print Document View Excel Document

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
Document and Entity Information - USD ($) $ in Millions	Dec. 31, 2018	Mar. 25, 2019	Jul. 19, 2018
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	FY
Trading Symbol	TLRY
Entity Registrant Name	TILRAY, INC.
Entity Central Index Key	0001731348
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 176
Class 1 Common Stock [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		16,666,667
Class 2 Common Stock [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		80,125,538

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Current assets:
Cash and cash equivalents	$ 487,255	$ 2,323
Short-term investments	30,335
Accounts receivable, net of allowance for doubtful accounts of $292 and $8 as of December 31, 2018 and 2017, respectively	16,525	983
Other receivables	969	1,131
Inventory	16,211	7,421
Prepaid expenses and other current assets	3,007	545
Total current assets	554,302	12,403
Property and equipment, net	80,214	39,985
Intangible assets, net	4,486	934
Investments	16,911
Deposits and other assets	754	626
Total assets	656,667	53,948
Current liabilities:
Accounts payable	10,649	5,563
Accrued expenses and other current liabilities	14,818	2,021
Accrued obligations under capital lease	470	379
Current portion of long-term debt		9,432
Privateer Holdings debt facilities		32,826
Total current liabilities	25,937	50,221
Accrued obligations under capital lease	8,286	8,579
Deferred tax liability	4,424
Convertible senior notes due 2023, net of issuance cost	420,367
Total liabilities	459,014	58,800
Stockholders' equity (deficit):
Capital stock (none authorized, issued or outstanding at December 31, 2018; 1 share authorized, issued and outstanding at December 31, 2017)	0	0
Additional paid-in capital	302,057	31,736
Accumulated other comprehensive income	3,763	3,866
Accumulated deficit	(108,177)	(40,454)
Total stockholders' equity (deficit)	197,653	(4,852)
Total liabilities and stockholders' equity (deficit)	656,667	$ 53,948
Class 1 common stock [Member]
Stockholders' equity (deficit):
Common stock value	2
Class 2 common stock [Member]
Stockholders' equity (deficit):
Common stock value	$ 8

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Accounts receivable, allowances	$ 292	$ 8
Capital stock, shares authorized	0	1
Capital stock, shares issued	0	1
Capital stock, shares outstanding	0	1
Class 1 common stock [Member]
Common stock, par value	$ 0.0001
Common stock, shares authorized	250,000,000	0
Common stock, shares issued	16,666,667	0
Common stock, shares outstanding	16,666,667	0
Class 2 common stock [Member]
Common stock, par value	$ 0.0001
Common stock, shares authorized	500,000,000	0
Common stock, shares issued	76,504,200	0
Common stock, shares outstanding	76,504,200	0

Consolidated Statements of Net Loss and Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Statement [Abstract]
Revenue	$ 43,130	$ 20,538	$ 12,644
Cost of sales	28,855	9,161	9,974
Gross margin	14,275	11,377	2,670
Research and development expenses	4,264	3,171	1,136
Sales and marketing expenses	15,366	7,164	3,599
General and administrative expenses	31,307	8,401	4,890
Stock-based compensation expense	20,988	139	94
Operating loss	(57,650)	(7,498)	(7,049)
Foreign exchange loss (gain), net	7,234	(1,363)	(186)
Interest expense, net	9,110	1,686	1,019
Other (income) expense, net	(1,820)	(12)	1
Loss before income taxes	(72,174)	(7,809)	(7,883)
Deferred income tax recovery	(4,485)
Current income tax expense	34
Net loss	$ (67,723)	$ (7,809)	$ (7,883)
Net loss per share - basic and diluted	$ (0.82)	$ (0.10)	$ (0.11)
Weighted average shares used in computation of net loss per share - basic and diluted	83,009,656	75,000,000	75,000,000
Net loss	$ (67,723)	$ (7,809)	$ (7,883)
Foreign currency translation gain	662	282	418
Unrealized gain (loss) on cash equivalents and investments	(765)
Comprehensive loss	$ (67,826)	$ (7,527)	$ (7,465)

Consolidated Statements of Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Convertible Preferred Shares [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Other Comprehensive Income [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2015	$ 9,899			$ 31,495	$ 3,166	$ (24,762)
Stock-based compensation expense	94			94
Foreign currency translation gain	418				418
Net loss	(7,883)					(7,883)
Ending Balance at Dec. 31, 2016	2,528			31,589	3,584	(32,645)
Contributions	8			8
Stock-based compensation expense	139			139
Foreign currency translation gain	282				282
Net loss	(7,809)					(7,809)
Ending Balance at Dec. 31, 2017	(4,852)			31,736	3,866	(40,454)
Issuance of convertible preferred stock net of issuance costs	52,560	$ 2		52,558
Issuance of convertible preferred stock net of issuance costs, Shares		7,794,042
Conversion of convertible preferred stock		$ (2)	$ 2
Conversion of convertible preferred stock, Shares		(7,794,042)	7,794,042
Issuance of common stock, net of issuance cost	160,792		$ 8	160,784
Issuance of common stock, net of issuance cost, Shares			85,350,000
Stock-based compensation expense	20,988			20,988
Foreign currency translation gain	662				662
Deferred tax liability related to convertible senior notes due 2023, net of issuance costs	(8,809)			(8,809)
Unrealized gain (loss) on cash equivalents and investments	(765)				(765)
Issuance of shares for Alef acquisition	2,855			2,855
Issuance of shares for Alef acquisition, Shares			26,825
Equity component related to issuance of convertible senior notes due 2023, net of issuance costs	41,945			41,945
Net loss	(67,723)					(67,723)
Ending Balance at Dec. 31, 2018	$ 197,653		$ 10	$ 302,057	$ 3,763	$ (108,177)
Ending Balance, Shares at Dec. 31, 2018			93,170,867

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Operating activities
Net loss	$ (67,723)	$ (7,809)	$ (7,883)
Adjusted for the following items:
Foreign currency loss (gain)	6,477	(1,363)	(187)
Provision for doubtful accounts and returns	285		9
Inventory write-downs	384	204	234
Depreciation and amortization	3,562	1,853	1,953
Stock-based compensation expense	20,988	139	94
Non-cash interest expense	5,669	693	772
Deferred income tax recovery	(4,485)
(Gain) Loss on disposal of property and equipment	(2)	11	2
Loss on sale of investment	6
Amortization of discount on convertible senior notes due 2023	2,180
Changes in non-cash working capital:
Accounts receivable	(16,512)	(507)	317
Other receivables	101	(1,187)	(1)
Inventory	(9,226)	(3,295)	693
Prepaid expenses and other current assets	(2,588)	(433)	(8)
Accounts payable	5,218	4,728	122
Accrued expenses and other current liabilities	9,418	963	565
Net cash used in operating activities	(46,248)	(6,003)	(3,318)
Investing activities
Decrease (increase) in deposits and other assets		(397)	6
Purchases of short-term and non-current investments	(319,373)
Proceeds from sale of short-term investments	274,497
Purchases of property and equipment	(50,198)	(10,910)	(488)
Proceeds from disposal of property and equipment	713	23
Purchases of intangible assets	(4,259)	(531)	(543)
Net cash used in investing activities	(98,620)	(11,815)	(1,025)
Financing activities
Repayment under Privateer Holdings debt facilities	(36,940)
Advances under Privateer Holdings debt facilities	3,453	6,039	4,406
Proceeds from Preferred Shares - Series A, net of transaction costs	52,560
Repayment of mortgage debt	(9,136)
Proceeds from mortgage debt			9,062
Payments on long-term debt			(2,190)
Long-term debt financing costs			(359)
Minimum lease payments under capital lease		(199)
Proceeds from issuance of convertible senior notes due 2023, net of issuance costs	460,269
Proceeds from issuance of common stock pursuant to IPO	176,091
Payment of costs from issuance of common stock pursuant to IPO	(15,299)
Net cash provided by financing activities	630,998	12,235	10,919
Effect of foreign currency translation on cash, cash equivalents and restricted cash	(1,198)	375	226
Cash, cash equivalents and restricted cash
Increase (decrease) in cash, cash equivalents and restricted cash	484,932	(5,208)	6,802
Cash and cash equivalents, beginning of period	2,323	7,531	729
Cash, cash equivalents and restricted cash, end of period	487,255	2,323	7,531
Supplemental Disclosure for Cash Flow Information
Cash paid for interest	1,189	1,157	$ 295
Non-cash financing activities
Capital lease obligation		8,958
Conversion of preferred stock to common stock	2
Non-cash investing
Addition to property and equipment under capital lease	114	8,958
Alef acquisition	$ 2,855
Privateer Holdings Construction Facility [Member]
Financing activities
Advances under Privateer Holdings debt facilities		$ 6,395

Description of Business and Summary

12 Months Ended

Dec. 31, 2018

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Description of Business and Summary

1. Description of Business and Summary

Tilray, Inc. (the “Company”) was incorporated in Delaware on January 24, 2018 as a wholly owned subsidiary of Privateer Holdings, Inc. (“Privateer Holdings”). On January 25, 2018, Privateer Holdings transferred the equity interest in Decatur Holdings, B.V. (“Decatur”) to Tilray, Inc. Decatur was subsequently dissolved on December 27, 2018.

Prior to the incorporation of Decatur on March 8, 2016, the four wholly owned subsidiaries of Privateer Holdings consisted of Tilray Canada, Ltd., Dorada Ventures, Ltd., Gatenhielm Group, CV, and High Park Farms, Ltd. and were capitalized with a nominal amount for each capital stock. In 2016, Privateer Holdings made capital contributions to Tilray Canada, Ltd. in the aggregate amount of $31,495. The equity interests of the four wholly owned subsidiaries were transferred to Decatur upon incorporation in 2016.

Subsequent to its formation, Decatur incorporated Tilray Deutschland GmbH, Tilray Portugal Unipessoal, Lda., Pardel Holdings, Lda. and Tilray Australia New Zealand Pty. Ltd.

The transfers of the equity interests described above were between entities under common control and were recorded at their carrying amounts. The consolidated financial statements of the Company (the “financial statements”) are prepared, on a continuity of interest basis, reflecting the historical financial information of Decatur prior to January 25, 2018.

The principal activities of the Company are the production and sale of medical and adult-use cannabis in Canada, as well as export and sale of medical cannabis from Canada into other jurisdictions. These activities were previously regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) under the Controlled Drugs and Substances Act; on October 17, 2018, the ACMPR was superseded by the Cannabis Regulations under the Cannabis Act. The Company’s license to cultivate, process and sell medical cannabis products in Canada was first granted on March 24, 2014.

Subsequently, the Company received a Licensed Dealer designation under Canada’s Narcotic Control Regulations (“NCR”) from Health Canada, allowing the Company to sell medical cannabis in Canada and export medical cannabis products to other countries in accordance with applicable laws. These licenses have now been consolidated under the Cannabis Regulations.

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2018

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of presentation

The accompanying consolidated financial statements (the “financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). To the extent relevant, the financial statements include expense allocations for certain corporate functions historically provided by Privateer Holdings. The assumptions underlying the financial statements, including the assumptions regarding allocated expenses, reasonably reflect the utilization of services provided to or the benefit received by the Company during the periods presented. The allocations may not however reflect the expenses the Company has incurred or will incur as a stand-alone company for the periods presented. Actual costs that may have been incurred if the Company had been a stand-alone company would depend on a number of factors, including the chosen organizational structure, which functions were outsourced or performed by employees and strategic decisions made in areas such as treasury, information technology, financial reporting and oversight.

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, as modified by the Jumpstart Our Business Start-ups Act of 2012, (the “JOBS Act”). Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 13(a) of the Securities Exchange Act of 1934, as amended, for complying with new or revised accounting standards applicable to public companies. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company has elected to take advantage of this extended transition period. As a result of this election, the Company’s financial statements may not be comparable to companies that comply with public company effective dates for such new or revised standards.

Basis of consolidation

These financial statements include the accounts of the following entities wholly owned by the Company as of December 31, 2018:


Name of entity	Date of formation	Place of incorporation
Tilray Canada, Ltd.	September 6, 2013	British Columbia, Canada
Dorada Ventures, Ltd.	October 18, 2013	British Columbia, Canada
High Park Farms, Ltd.	February 19, 2016	British Columbia, Canada
Tilray Deutschland GmbH	November 3, 2016	Germany
Tilray Portugal Unipessoal, Lda.	April 5, 2017	Portugal
Pardal Holdings, Lda.	April 24, 2017	Portugal
Tilray Australia New Zealand Pty. Ltd.	May 9, 2017	Australia
High Park Holdings, Ltd.	February 8, 2018	British Columbia, Canada
National Cannabinoid Clinics Pty Ltd.	September 19, 2018	Australia
Tilray Latin America SpA	November 5, 2018	Chile
Tilray Portugal II, Lda.	December 11, 2018	Portugal

Tilray, Inc. was incorporated in Delaware in January 2018. Prior to January 2018, we operated our business under Decatur, which was formed in March 2016. Decatur was incorporated under the laws of the Netherlands on March 8, 2016 as a wholly owned subsidiary of Privateer Holdings to hold a 100% ownership interest in the underlying entities included above. Decatur has been disolved as of December 31, 2018. The entities listed above are wholly owned by the Company and have been formed to support the intended operations of the Company and all intercompany transactions and balances have been eliminated in the financial statements of the Company.

Use of estimates

The preparation of the financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts in the financial statements and accompanying notes. Actual results may differ from these estimates. Key estimates in these financial statements include the allowance for doubtful accounts, inventory write-downs, capitalization of internally developed software costs, estimated useful lives of property, plant and equipment and intangible assets, valuation allowance on deferred income tax assets, fair value of stock options granted under Privateer Holdings’ equity-based compensation plan (the “Original Plan”) and the new 2018 Equity Incentive Plan (the “New Plan”) and the fair value of the Convertible Senior Notes due 2023 (“Convertible Notes”) and equity component.

Foreign currency

These financial statements are presented in the United States dollar (“USD”), which is the Company’s reporting currency. Functional currencies for the entities in these financial statements are their respective local currencies, including the Canadian dollar (“CAD”), Australian dollar, Chilean Peso and the Euro.

The assets and liabilities of each entity are translated to USD at the exchange rate in effect as at December 31, 2018 and 2017. Certain transactions affecting the stockholders’ equity (deficit) are translated at historical foreign exchange rates. The statements of net loss and comprehensive loss and statements of cash flows are translated to USD applying the average foreign exchange rate in effect during the reporting period. The resulting translation adjustments are included in other comprehensive loss.

Monetary assets and liabilities denominated in foreign currencies are translated to the functional currency by applying the foreign exchange rate in effect at the balance sheet date. Revenues and expenses are translated using the average foreign exchange rate for the reporting period. Realized and unrealized foreign currency differences are recognized in the statement of net loss and comprehensive loss.

Net loss per share

Basic net loss per share is computed by dividing reported net loss by the weighted average number of common shares outstanding for the reported period. Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock of the Company during reported periods. Diluted net loss per share is computed by dividing net loss by the sum of the weighted average number of common shares and the number of dilutive potential common share equivalents outstanding during the period. Potential dilutive common share equivalents consist of the incremental common shares issuable upon the exercise of vested share options and the incremental shares issuable upon conversion of the Convertible Notes. Potential dilutive common share equivalents consist of stock options, restricted stock units (“RSUs”) and restricted stock awards.

In computing diluted earnings per share, common share equivalents are not considered in periods in which a net loss is reported, as the inclusion of the common share equivalents would be anti-dilutive. As of December 31, 2018, there were 7,902,263 common share equivalents with potential dilutive impact. Since the Company is in a net loss for all periods presented in these financial statements, there is no difference between the Company’s basic and diluted net loss per share for the periods presented. There were no common share equivalents that would have a dilutive impact in 2016 and 2017.

Cash and cash equivalents

Cash and cash equivalents are comprised of cash and highly liquid investments that are readily convertible into known amounts of cash with original maturities of three months or less.

Cash and cash equivalents include amounts held primarily in U.S. dollar, Canadian dollar, Euro, Australian dollar, Chilean peso, corporate bonds, commercial paper, treasury bills and money market funds.

Investments

Investments consist of treasury bills and equity securities. Equity securities generally consist of securities that represent ownership interests in an enterprise for which do not have significant influence or a controlling interest. The Company’s investments are classified as available-for-sale securities or as a cost method investment.

Available-for-sale securities

Securities classified as available-for-sale are recorded at fair value. Unrealized gains and losses during the year, net of the related tax effect applicable to available-for-sale, are excluded from income and reflected in other comprehensive income (“OCI”), and the cumulative effect is reported as a separate component of shareholders’ equity until realized. If a decline in fair value is deemed to be other-than-temporary, the investment is written down to its fair value and the amount of the write-down is recorded as other-than-temporary impairment (“OTTI”) loss in the statement of net loss. Any portion of such decline related to the securities that are not held-to-maturity and is believed to arise from factors other than credit is recorded as a component of other comprehensive income rather than against income.

Net realized gains and losses on investments are determined in accordance with the specific identification method.

Cost method investments

Equity securities for which the fair value is not readily determinable are carried at cost. Distributions from the equity security are recognized as income dividend when received.

An impairment charge is recorded if the carrying amount of the investment exceeds its fair value and determined to be other-than-temporary.

Fair value measurements

The carrying value of the Company’s accounts receivable, other receivables, accounts payable, accrued expenses and other current liabilities approximate their fair value due to their short-term nature. Investments classified as available-for-sale are recorded at fair value. The estimated fair value for securities held is determined using quoted market prices or broker or dealer quotations.

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In estimating the fair value of an asset or a liability, the Company takes into account the characteristics of the asset or liability if market participants would take those characteristics into account when pricing the asset or liability at the measurement date.

Inventory

Inventory is comprised of raw materials, finished goods and work-in-progress such as pre-harvested cannabis plants and by-products to be extracted. The costs of growing cannabis including but not limited to labor, utilities, nutrition and irrigation, are capitalized into inventory until the time of harvest.

Inventory is stated at the lower of cost or net realizable value, determined using weighted average cost. Cost includes expenditures directly related to manufacturing and distribution of the products. Primary costs include raw materials, packaging, direct labor, overhead, shipping and the depreciation of manufacturing equipment and production facilities determined at normal capacity. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance and property taxes.

Net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. At the end of each reporting period, the Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost or net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable items.

Property and equipment

Property and equipment are recorded at cost net of accumulated depreciation. Assets held under capital leases are capitalized at the commencement of the lease at the lower of the present value of minimum lease payments at the inception of the lease or fair value. Depreciation is computed using the straight-line method over the estimated useful lives of the assets. The estimated useful life of buildings is 20 years and the estimated useful life of property and equipment, other than buildings, ranges from three to seven years. Land is not depreciated. Leasehold improvements are amortized over the lesser of the asset’s estimated useful life or the remaining lease term.

When assets are retired or disposed of, the cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized. Maintenance and repairs are charged to expense as incurred. Significant expenditures, which extend the useful lives of assets or increase productivity, are capitalized. When significant parts of an item of property and equipment have different useful lives, they are accounted for as separate items or components of property and equipment.

Construction in progress includes construction progress payments, deposits, engineering costs, interest expense for debt financing on long-term construction projects and other costs directly related to the construction of the facilities. Expenditures are capitalized during the construction period and construction in progress is transferred to the relevant class of property and equipment when the assets are available for use, at which point the depreciation of the asset commences.

Intangible assets

The Company capitalizes certain internal-use software development costs, consisting primarily of contractor costs and employee salaries and benefits allocated to the software. Capitalization of costs incurred in connection with internally developed software commences when both the preliminary project stage is completed and management has authorized further funding for the project, based on a determination that it is probable the project will be completed and used to perform the function intended. Capitalization of costs ceases no later than the point at which the project is substantially complete and ready for its intended use. All other costs are expensed as incurred. Amortization is calculated on a straight-line basis over three years. Costs incurred for enhancements that are expected to result in additional functionalities are capitalized.

The estimated useful lives are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.

Intangible assets also include the license acquired as part of the acquisition of Alef Biotechnology SpA (“Alef”). The acquistion of Alef was accounted for as an asset acquisition as it did not meet the defintion of a business.

Impairment of long-lived assets

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. In order to determine if assets have been impaired, assets are grouped and tested at the lowest level for which identifiable independent cash flows are available (“asset group”). An impairment loss is recognized when the sum of projected undiscounted cash flows is less than the carrying value of the asset group. The measurement of the impairment loss to be recognized is based on the difference between the fair value and the carrying value of the asset group. Fair value can be determined using a market approach, income approach or cost approach. The reversal of impairment losses is prohibited.

Capitalization of interest

Interest incurred relating to the construction or expansion of facilities is capitalized to the construction in progress. The Company ceases the capitalization of interest when construction activities are substantially completed and the facility is available for commercial use.

Leases

The Company enters into various leases in conducting its business. At the inception of each lease, the Company evaluates the lease agreement to determine whether the lease is an operating or capital lease. A capital lease is a lease in which 1) ownership of the property transfers to the lessee by the end of the lease term; 2) the lease contains a bargain purchase option; 3) the lease term is equal to 75% or more of the economic life of the leased property; or 4) the present value of the minimum lease payment at the inception of the lease term equals or exceeds 90% of the fair value of the leased property.

An asset and a corresponding liability are established at inception for capital leases. The capital lease assets are included in property, plant and equipment and the capital lease obligations are included in accrued obligations under capital lease. Operating lease payments are recognized as an expense on a straight-line basis over the lease term.

Convertible Senior Notes due 2023

The Company accounts for its Convertible Notes with a cash conversion feature in accordance with ASC 470-20 “Debt with Conversion and Other Options” which requires the liability and equity components of convertible debt instruments that may be settled in cash upon conversion, including partial cash settlement, to be separately accounted for in a manner that reflects the issuer’s nonconvertible debt borrowing rate. The initial proceeds from the sale of Convertible Notes are allocated between a liability component and an equity component in a manner that reflects interest expense at the rate of similar nonconvertible debt that could have been issued at such time. The equity component represents the excess initial proceeds received over the fair value of the liability component of the notes as of the date of issuance. The resulting debt discount is amortized over the five-year period during which the Convertible Notes are expected to be outstanding as additional non-cash interest expense.

Upon repurchase of convertible debt instruments, ASC 470-20 requires the issuer to allocate total settlement consideration, inclusive of transaction costs, amongst the liability and equity components of the instrument based on the fair value of the liability component immediately prior to repurchase. The difference between the settlement consideration allocated to the liability component and the net carrying value of the liability component, including unamortized debt issuance costs, would be recognized as gain (loss) on extinguishment of debt in the Consolidated Statements of Net Loss and Comprehensive Loss. The remaining settlement consideration allocated to the equity component would be recognized as a reduction of additional paid-in capital in the Consolidated Balance Sheets.

Revenue recognition

The Company recognizes revenue as earned when the following four criteria have been met: (i) when persuasive evidence of an arrangement exists, (ii) the product has been delivered to a customer, (iii) the sales price is fixed or determinable, and (iv) collection is reasonably assured. Revenue is recognized net of sales incentives and returns, after discounts for the assurance program, veterans coverage program and compassionate programs.

Direct-to-patient sales are recognized when the products are shipped to the customers. Bulk and adult-use sales under wholesale agreements are recognized based on the shipping terms of the agreements. Export sales under pharmaceutical distribution and pharmacy supply agreements are recognized when products are delivered to the end customers or patients.

Customer loyalty awards are accounted for as a separate component of the sales transaction in which they are granted. A portion of the consideration received in a transaction that includes the issuance of an award is deferred until the awards are ultimately redeemed. The allocation of the consideration to the award is based on an evaluation of the award’s estimated fair value at the date of the transaction. The customer loyalty program was discontinued in September 2017 and all customer loyalty awards expired as at December 31, 2017.

Cost of sales

Cost of sales represents costs directly related to manufacturing and distribution of the Company’s products. Primary costs include raw materials, packaging, direct labor, overhead, shipping and handling and the depreciation of manufacturing equipment and production facilities. Manufacturing overhead and related expenses include salaries, wages, employee benefits, utilities, maintenance and property taxes. The Company recognizes the cost of sales as the associated revenues are recognized.

Stock-based compensation

The Company measures and recognizes compensation expense for stock options and RSUs on a straight-line basis over the vesting period based on their grant date fair values. The Company estimates the fair value of stock options on the date of grant using the Black-Scholes option pricing model. The fair value of RSUs is based on the share price as at date of grant. For stock options and RSUs granted in May and June 2018, prior to the Company’s IPO, the fair value of common stock at the date of grant was determined by the Board of Directors with assistance from third-party valuation specialists. The Company estimates forfeitures at the time of grant and revises these estimates in subsequent periods if actual forfeitures differ from those estimates.

The critical assumptions and estimates used in determining the fair value of stock-based compensation on the grant date are: fair value of common shares on the grant date, risk-free interest rate, share price volatility of comparable companies, and the expected term.

For performance-based stock options and RSUs, the Company records compensation expense over the estimated service period once the achievement of the performance-based milestone is considered probable. At each reporting date, the Company assesses whether achievement of a milestone is considered probable, and if so, records compensation expense based on the portion of the service period elapsed to date with respect to that milestone, with a cumulative catch-up, net of estimated forfeitures. The Company will recognize remaining compensation expense with respect to a milestone, if any, over the remaining estimated service period.

Income taxes

The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Management makes an assessment of the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized.

The Company recognizes uncertain income tax positions at the largest amount that is more likely than not to be sustained upon audit by the relevant taxing authority. An uncertain income tax position will not be recognized if it has less than a 50% likelihood of being sustained. Changes in recognition or measurement are reflected in the period in which judgment occurs.

New accounting pronouncements not yet adopted

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), a new standard on revenue recognition. Further, the FASB has issued a number of additional ASUs regarding the new revenue recognition standard. The new standard, as amended, will supersede existing revenue recognition guidance and apply to all entities that enter into contracts to provide goods or services to customers. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers – Deferral of the Effective Date, which amends ASU 2014-09 to defer the effective date by one year. For public companies, the new standard is effective for annual reporting periods beginning after December 31, 2017, including interim periods within that reporting period. For all other entities, including emerging growth companies, this standard is effective for annual reporting periods beginning after December 15, 2018. The Company is evaluating the impact and expects to implement the provisions of ASU 2014-09 for the annual periods beginning on January 1, 2019. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements.

In January 2016, the FASB issued ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10) – Recognition and Measurement of Financial Assets and Financial Liabilities. ASU 2016-01 is intended to enhance the reporting model for financial instruments to provide users of financial statements with more decision-useful information. For public companies, the new standard is effective for annual periods beginning after December 15, 2017, including interim periods within the fiscal year. For all other entities, including emerging growth companies, ASU 2016-01 is effective for annual periods beginning after December 15, 2018, and interim periods within those annual periods beginning after December 15, 2019. The Company is evaluating the impact and expects to implement the provisions of ASU 2016-01 for the annual periods beginning on January 1, 2019.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which supersedes the current accounting for leases and while retaining two distinct types of leases, finance and operating, (1) requires lessees to record a right of use asset and a related liability for the rights and obligations associated with a lease, regardless of lease classification, and recognize lease expense in a manner similar to current accounting, (2) eliminates most real estate specific lease provisions, and, (3) aligns many of the underlying lessor model principles with those in the new revenue standard. Leases with a term of 12 months or less will be accounted for similar to existing guidance for operating leases today. For public companies, the new standard is effective for annual and interim periods in fiscal years beginning after December 15, 2018. For all other entities, including emerging growth companies, this standard is effective for annual reporting periods beginning after December 15, 2019, and interim periods within fiscal years beginning after December 2020. Earlier application is permitted. The Company expects to implement the provisions of ASU 2016-02 for annual periods beginning January 1, 2020. The Company is currently evaluating the impact of the new standard on the Company’s financial statements.

In March 2016, the FASB issued ASU 2016-09, Compensation – Stock Compensation (Topic 718). ASU 2016-09 is intended to simplify the accounting for share-based payment transactions, including income tax consequences, classification of awards as either assets or liabilities and classification on the statement of cash flows. ASU 2016-09 is effective for annual periods beginning after December 15, 2017 and interim periods within annual periods beginning after December 15, 2018. The Company expects to implement the provisions of ASU 2016-09 as of January 1, 2019. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires the measurement of all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. Adoption of ASU 2016-13 will require financial institutions and other organizations to use forward-looking information to better formulate their credit loss estimates. In addition, the ASU amends the accounting for credit losses on available for sale debt securities and purchased financial assets with credit deterioration. This update will be effective for fiscal years beginning after December 15, 2020 and interim periods within fiscal years beginning after December 15, 2021. The Company expects to implement the provisions of ASU 2016-13 as of January 1, 2022. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements.

In August 2018, the FASB issued ASU 2018-13, Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820). ASU 2018-13 adds, modifies, and removes certain fair value measurement disclosure requirements. ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019. Early adoption is permitted. The Company is currently evaluating the effect of adopting this ASU on the Company’s financial statements.

Investments

12 Months Ended

Dec. 31, 2018

Investments Debt And Equity Securities [Abstract]

Investments

3. Investments

The Company’s short-term investments are classified as available-for-sale investments and the long-term investments are classified as either available-for-sale or cost method investments.

The following table summarizes the unrealized gains and losses and estimated fair value of our short-term investments as of December 31, 2018:

Cost

Gross

unrealized

gains

Gross

unrealized

losses

Fair

value

Treasury bills

30,367

30,335

Total

30,367

30,335

Our short-term investments consist of treasury bills, which are deemed to be low risk based on their credit ratings from the major rating agencies. All our short-term investments have contractual maturities of one year or less.

The following table summarizes the unrealized gains and losses and estimated fair value of our long-term investments as of December 31, 2018:

Cost

Gross

unrealized

gains

Gross

unrealized

losses

Fair

value

Investment in equities

17,713

—

802

16,911

Total

17,713

—

802

16,911

Our investment in equities are reported in long-term investments on our Consolidated Balance Sheets. The following table provides a summary of the classification of our investment in equities:

	December 31,
	2018		2017
Investments in equities under available-for-sale method	$	1,845	$	—
Investment in equities under the cost method		15,066		—
Total investment in equities	$	16,911	$	—

Total unrealized loss recognized to other comprehensive income related to the long-term available-for-sale equity securities during the year was $802.

As at December 31, 2017, the Company did not hold any short-term and long-term investments.

Fair Value Measurement

12 Months Ended

Dec. 31, 2018

Fair Value Disclosures [Abstract]

Fair Value Measurement

4. Fair Value Measurement

The Company complies with FASB ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2018 and 2017, and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. In general, fair values determined by Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. Fair values determined by Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. Fair values determined by Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability:

	Quoted prices in active markets for identical assets (Level 1)		Other observable inputs (Level 2)		Significant unobservable inputs (Level 3)		Total
December 31, 2018
Cash equivalents:
Money market fund	$	33,111	$	—		—	$	33,111
Corporate bonds		7,796		—		—		7,796
Commercial paper		9,975		—		—		9,975
Treasury bills		152,879		—		—		152,879
Total cash equivalents		203,761		—		—		203,761
Investments:
Treasury bills		30,335		—		—		30,335
Investment in equities		1,163		682		—		1,845
Total investments		31,498		682		—		32,180
Total	$	235,259	$	682	$	—	$	235,941

The cash equivalents carrying amount as of 2018 includes an unrealized gain of $69, which is recorded in other comprehensive income. As at December 31, 2017 the Company did not hold any assets that were measured at fair value.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Inventory

12 Months Ended

Dec. 31, 2018

Inventory Disclosure [Abstract]

Inventory

5. Inventory

Inventory is comprised of the following items:

	December 31,
	2018		2017
Raw materials	$	2,132	$	163
Work-in-process – dry cannabis		9,982		1,396
Work-in-process – cannabis extracts		2,830		30
Finished goods – dry cannabis		113		3,501
Finished goods – cannabis extracts		1,083		2,158
Finished goods – accessories		71		173
Total	$	16,211	$	7,421

Inventory is written down for any obsolescence or when the net realizable value of inventory is less than the carrying value. For the year ended December 31, 2018, the Company recorded write-downs related to inventory within work-in-process of $4,561 (2017 – $617), in cost of sales.

Property and Equipment, Net

12 Months Ended

Dec. 31, 2018

Property Plant And Equipment [Abstract]

Property and Equipment, Net

6. Property and Equipment, Net

Property and equipment, net consisted of the following:

	December 31,
	2018			2017
Land	$	4,498		$	2,547
Buildings and leasehold improvements		51,111			19,569
Laboratory and manufacturing equipment		6,131			2,815
Office and computer equipment		970			571
Assets under capital lease		9,661			9,191
Construction in process		15,343			9,872
		87,714			44,565
Less: accumulated depreciation and amortization		(7,500	)		(4,580	)
Total	$	80,214		$	39,985

Depreciation expense included in cost of sales relating to manufacturing equipment and production facilities for the year ended December 31, 2018 is $1,964 (2017 – $1,303 and 2016 – $1,247). Depreciation expense included in general administrative expenses related to general office space and equipment for the year ended December 31, 2018 is $149 (2017 – $95 and 2016 – $92). The remaining depreciation is included in inventory.

For the year ended December 31, 2018, there is $158 (2017 – $34) of capitalized interest included in construction-in-progress.

Intangible Assets

12 Months Ended

Dec. 31, 2018

Goodwill And Intangible Assets Disclosure [Abstract]

Intangible Assets

7. Intangible Assets

Intangible assets are comprised of the following items:

			December 31,
			2018						2017
	Weighted Average Amortization Period (in years)		Cost		Accumulated Amortization		Net		Cost		Accumulated Amortization		Net
Amortizing intangible assets:
Website		3	$	3,755	$	2,253	$	1,502	$	2,813	$	1,879	$	934
Total				3,755		2,253		1,502		2,813		1,879		934
Other intangible assets:
Alef license		—		2,984		—		2,984		—		—		—
Total				2,984		—		2,984		—		—		—
Total intangible assets			$	6,739	$	2,253	$	4,486	$	2,813	$	1,879	$	934

The net carrying value of intangible assets as of December 31, 2018 includes $43 (December 31, 2017 – $381) of intangible assets under construction, relating to expenditures incurred to develop additional functionalities for the patient portal.

Intangible asset additions in 2018 included a licence acquired as part of the Alef acquisition. The value of the license is $2,984. Refer to Note 16 for detail description.

The amortization expense for the next five years on intangibles assets in use are as follows: 2019 – $731; 2020 – $431; 2021 – $340; and thereafter – nil.

Accounts Payable and Accrued Expenses

12 Months Ended

Dec. 31, 2018

Payables And Accruals [Abstract]

Accounts Payable and Accrued Expenses

8. Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses are comprised of the following items:

	December 31,
	2018		2017
Accounts payable - trade	$	9,716	$	5,563
Accounts payable - related parties		933		—
Accrued interest on convertible senior notes due 2023		5,302		—
Accrued legal fees		565		10
Accrued payroll		3,278		610
Other accrued expenses		5,673		1,401
Total	$	25,467	$	7,584

Long-Term Debt

12 Months Ended

Dec. 31, 2018

Debt Disclosure [Abstract]

Long-Term Debt

9. Long-Term Debt

Long-term debt is as follows:

	December 31,
	2018		2017
Mortgage payable, due January 2019, annual interest 11.5%	$	—	$	9,537
Unamortized deferred financing costs		—		(105	)
		—		9,432
Less current portion of long-term debt		—		(9,432	)
Total	$	—	$	—

In December 2016, Tilray Canada, Ltd. entered into a mortgage for an amount of $8,909 ($12,000 CAD) with an annual interest rate of 11.5% maturing in June 2018. In July 2018, the Company entered into a Mortgage Loan Extension Agreement to extend the mortgage. The term of the mortgage was extended for a further period of six months to January 1, 2019 with a renewal fee of CAD $90, or .75 basis points of the loan balance.

The mortgage was secured by a deed of trust on all assets of Tilray Canada, Ltd. and was guaranteed by Privateer Holdings. The carrying value of the mortgage approximates its fair value because the interest rate on the mortgage is equivalent to current market rates. In October 2018, the Company repaid the outstanding mortgage balance.

Convertible Senior Notes Due 2023

12 Months Ended

Dec. 31, 2018

Debt Disclosure [Abstract]

Convertible Senior Notes Due 2023

10. Convertible Senior Notes Due 2023

In October 2018 the Company issued Convertible Notes with a face value of $475,000. The net proceeds from the offering were approximately $460,134, after deducting commissions and other fees and expenses payable by the Company.

The Convertible Notes bear interest at a rate of 5.00% per annum, payable semi-annually in arrears on April 1 and October 1 of each year, beginning on April 1, 2019. Additional interest may accrue on the Convertible Notes in specified circumstances. The Convertible Notes will mature on October 1, 2023, unless earlier repurchased, redeemed or converted. There are no principal payments required over the five year term of the Convertible Notes, except in the case of redemption or events of defaults.

The Convertible Notes are governed by an Indenture between the Company, as issuer, and GLAS Trust Company LLC, as trustee. The Convertible Notes are the Company’s general unsecured obligations and rank senior in right of payment to all of the Company’s indebtedness that is expressly subordinated in right of payment to the notes; equal in right of payment with any of the Company’s unsecured indebtedness that is not so subordinated; effectively junior in right of payment to any of Company’s secured indebtedness to the extent of the value of the assets securing such indebtedness; and structurally junior to all indebtedness and other liabilities (including trade payables but excluding intercompany obligations) of the Company’s current or future subsidiaries.

The Indenture includes customary covenants and sets forth certain events of default after which the Convertible Notes may be declared immediately due and payable, including certain types of bankruptcy or insolvency involving the Company.

To the extent the Company so elects, the sole remedy for an event of default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture will, for the first 365 days after such event of default, consist exclusively of the right to receive additional interest on the notes. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock, at the Company’s election (the “cash conversion option”). The initial conversion rate for the Convertible Notes is 5.9735 shares of common stock per one thousand dollar principal amount of notes, which is equivalent to an initial conversion price of approximately $167.41 per share of common stock. Throughout the term of the Convertible Notes, the conversion rate may be adjusted upon the occurrence of certain events.

Prior to the close of business on the business day immediately preceding April 1, 2023, the Convertible Notes will be convertible only under the specified circumstances. On or after April 1, 2023 until the close of business on the business day immediately preceding the maturity date, holders may convert all or any portion of their Convertible Notes, in multiples of one thousand dollar principal amount, at the option of the holder regardless of the forementioned circumstances.

As a result of the cash conversion option, the Company separately accounts for the value of the embedded conversion option as a component of equity. The value of the embedded conversion option is the residual of the net proceeds of the issuance, less the estimated fair value of the debt without the conversion feature, and amounted to $57.6 million at issuance. The estimated fair value of the debt without the conversion feature, was determined using the expected cash flows of the Convertible Notes discounted by the estimated interest rate of similar nonconvertible debt; the debt discount is being amortized as additional non-cash interest expense over the term of the Convertible Notes using the interest method with an effective interest rate of 8% per annum. The equity component is not remeasured as long as it continues to meet the conditions for equity classification.

As of December 31, 2018, the Convertible Notes are not yet convertible. The Convertible Notes will become convertible upon the satisfaction of the above circumstances. In accounting for the transaction costs related to the issuance of the Convertible Notes, the Company allocated the total amount of offering costs incurred to the debt and equity components based on their relative values. Direct issue costs attributable to the debt component, totaling $13,467, are being amortized as non-cash interest expense over the term of the Convertible Notes, and offering costs attributable to the equity component, totaling $1,398, were recorded within stockholders’ equity (deficit).

As at December 31, 2018, the Company was in compliance with all the covenants set forth under the Indenture.

The following table sets forth the net carrying amount of the Convertible Notes:

	December 31, 2018
5.00% Convertible Senior Notes	$	475,000
Unamortized discount		(41,687	)
Unamortized transaction costs		(12,946	)
Net carrying amount	$	420,367

The following table sets forth total interest expense recognized related to the Convertible Notes:

	Year ended December 31, 2018
Contractual coupon interest	$	5,302
Amortization of discount		2,152
Amortization of direct issue costs		28
Total	$	7,482

Capital Stock

12 Months Ended

Dec. 31, 2018

Equity [Abstract]

Capital Stock

11. Capital Stock

Capital Stock

As of December 31, 2017, the Company had authorized, issued and outstanding one share of capital stock with a one dollar par value. Each share of capital stock was entitled to one vote. As of December 31, 2018, no shares of capital stock were authorized, issued or outstanding.

Common and Convertible Preferred Stock

The Company’s certificate of incorporation authorized the Company to issue the following classes of shares with the following par value and voting rights as of December 31, 2018.

	Par Value		Authorized		Voting Rights
Class 1 common stock	$	0.0001		250,000,000	10 votes for each share
Class 2 common stock	$	0.0001		500,000,000	1 vote for each share
Convertible preferred stock	$	0.0001		10,000,000	N/A

In February 2018, the Company completed a recapitalization in which the Company issued 75,000,000 shares of Class 1 common stock to Privateer Holdings in exchange for the net assets of Decatur Holdings, BV. Of which 58,333,333 Class 1 common stock was converted into Class 2 common stock upon IPO, resulting in Privateer share ownership of 58,333,333 of Class 2 common stock and 16,666,667 of Class 1 common stock.

In July 2018, the Company completed its IPO, whereby 10,350,000 shares of our Class 2 common stock were sold at a price of $17.00 ($22.45 CAD) per share, which included 1,350,000 shares pursuant to the underwriters’ option to purchase additional shares. Upon the closing of the IPO, all shares of the outstanding Series A preferred stock automatically converted into 7,794,042 shares of Class 2 common stock on a one-for-one basis.

The liquidation and dividend rights are identical among Class 1 common stock and Class 2 common stock, and all classes of common stock share equally in our earnings and losses.

In February and March 2018, the Company issued an aggregate of 7,794,042 shares of Series A preferred stock at an issue price of $7.10 ($8.90 CAD) per share. In July 2018, the Company completed its IPO and upon the closing of the IPO, all shares of the outstanding Series A preferred stock automatically converted into 7,794,042 shares of Class 2 common stock on a one-for-one basis.

General and Administrative Expenses

12 Months Ended

Dec. 31, 2018

General And Administrative Expense [Abstract]

General and Administrative Expenses

12. General and Administrative Expenses

General and administrative expenses are comprised of the following items:

	Year ended December 31,
	2018		2017		2016
Salaries	$	11,721	$	3,717	$	2,640
Professional fees		7,557		1,715		424
Travel expenses		2,031		287		109
Depreciation and amortization		1,598		902		591
Other expenses		8,400		1,780		1,126
Total	$	31,307	$	8,401	$	4,890

Stock-Based Compensation

12 Months Ended

Dec. 31, 2018

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock-Based Compensation

13. Stock-Based Compensation

Original Stock Option Plan

Certain employees of the Company participate in the Original Plan. For the year ended December 31, 2018, the total stock-based compensation expense associated with the Original Plan was $359 (December 31, 2017 – $139 and 2016 – $94).

The Original Plan has 6,760,879 shares of Privateer Holdings common stock reserved for issuance under the Original Plan. Stock options granted under the Original Plan may be either incentive stock options or nonqualified stock options. Stock options and shares of Privateer Holdings common stock issued under the Original Plan are determined by the Board of Directors of Privateer Holdings and may not be issued at less than 100% of the fair value of the shares on the date of the grant. Fair value is determined by the Board of Directors of Privateer Holdings. Stock options will generally vest over a period of four years and expire, if not exercised, 10 years from the date of grant. Shares of Privateer Holdings common stock may be issued in exchange for services based on the fair value of the services or the fair value of the Privateer Holdings common stock at the time of grant, as determined by the Board of Directors of Privateer Holdings. The compensation expense under the Original Plan is allocated from Privateer Holdings to Tilray employees who holds options under the Original Plan.

The fair value of each stock option to employees granted under the Original Plan is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions:

	2018			2017			2016
Expected stock option life	5.15 years			5.84 years			6.05 years
Expected volatility		48.82	%		56.23	%		63.32	%
Risk-free interest rate		2.35	%		2.01	%		1.46	%
Expected dividend yield		-	%		-	%		-	%

The expected life of the stock options represents the period of time stock options are expected to be outstanding and is estimated considering vesting terms and employees’ historical exercise and post-vesting employment termination behavior. Expected volatility is based on historical volatilities of public companies operating in a similar industry to Privateer Holdings. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The expected dividend yield was determined based on the stock option’s exercise price and expected annual dividend rate at the time of grant.

Stock option activity for the Company under the Original Plan is as follows:

	Stock Options			Weighted- average exercise price		Weighted-average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2017		364,571		$	2.41		7.9	$	1,185
Granted		304,942			5.92
Exercised		(45,688	)		1.81
Forfeited		(25,881	)		5.14
Cancelled		(5,350	)		3.29
Balance December 31, 2018		592,594		$	4.14		8.1	$	989
Vested and expected to vest, December 31, 2018		522,301		$	3.94		8.0	$	955
Vested and exercisable, December 31, 2018		286,393		$	2.85		7.2	$	805

The weighted-average fair values of all stock options granted in 2018, 2017 and 2016 were $3.05, $1.79 and $1.91, respectively. The total intrinsic values of stock options exercised in 2018, 2017 and 2016 were $176, $19 and $51, respectively. As of December 31, 2018, the total remaining unrecognized compensation expense related to non-vested stock options amounted to $557, which will be amortized over the weighted-average remaining requisite service period of approximately 1.1 years. The total fair values of stock options vested in 2018, 2017 and 2016 were $276, $145 and $118, respectively.

New Stock Option and Restricted Stock Unit Plan

The Company adopted the New Plan, which was amended and approved by stockholders in May 2018. The New Plan authorizes the award of stock options and RSUs to employees, including officers, non-employee directors and consultants and the employees and consultants of our affiliates. Shares subject to awards granted under the New Plan that expire or terminate without being exercised in full, or that are paid out in cash rather than in shares, do not reduce the number of shares available for issuance under the New Plan. Additionally, shares become available for future grant under the New Plan if they were issued under the New Plan and if the Company repurchases them or they are forfeited. This includes shares used to pay the exercise price of an award or to satisfy the tax withholding obligations related to an award. The maximum number of shares of common stock subject to stock awards granted under the New Plan or otherwise during any one calendar year to any non-employee director, taken together with any cash fees paid by the Company to such non-employee director during such calendar year for service on the board of directors, will not exceed five hundred thousand dollars in total value, calculating the value of any such stock awards based on the grant date fair value of such stock awards for financial reporting purposes, or, with respect to the calendar year in which a nonemployee director is first appointed or elected to our board of directors, one million dollars.

Stock options represent the right to purchase shares of our Class 2 common stock on the date of exercise at a stated exercise price. The exercise price of a stock option generally must be at least equal to the fair market value of our shares of Class 2 common stock on the date of grant. Our compensation committee may provide for stock options to be exercised only as they vest or to be immediately exercisable with any shares issued on exercise being subject to our right of repurchase that lapses as the shares vest. The maximum term of stock options granted under the New Plan is ten years.

RSUs represent an offer by the Company to issue or sell shares of our Class 2 common stock subject to vesting restrictions, which may lapse based on time or achievement of performance conditions. Unless otherwise determined by our compensation committee at the time of grant, vesting will cease on the date the participant no longer provides services to the Company and unvested shares will be forfeited or repurchased by the Company. If an RSU has not been forfeited, then on the date specified in the RSUs, the Company will deliver to the holder a number of whole shares of Class 2 common stock, cash or a combination of shares of our Class 2 common stock and cash. Additionally, dividend equivalents may be credited in respect of shares covered by the RSUs. Any additional shares covered by the RSU credited by reason of such dividend equivalents will be subject to all of the same terms and conditions of the underlying RSU agreement to which they relate. The RSUs generally vest over a 3-or-4 year period. The fair value of RSUs are based on the share price as at date of grant.

Stock appreciation rights (“SAR”) provide for a payment, or payments, in cash or shares of Class 2 common stock to the holder based upon the difference between the fair market value of shares of our Class 2 common stock on the date of exercise and the stated exercise price. The maximum term of SARs granted under the New Plan is ten years. No SARs were issued in 2018.

The New Plan permits the grant of performance-based stock and cash awards. The performance goals may be based on company-wide performance or performance of one or more business units, divisions, affiliates or business segments and may be either absolute or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. The length of any performance period, the performance goals to be achieved during the performance period, and the measure of whether and to what degree such performance goals have been attained will be conclusively determined by the board of directors.

As of May 21, 2018, 9,199,338 shares of Class 2 common stock had been reserved for issuance under the New Plan. The number of shares of Class 2 common stock reserved for issuance under the New Plan will automatically increase on January 1 of each calendar year, for a period of not more than ten years, starting on January 1, 2019 and ending on and including January 1, 2027, in an amount equal to 4% of the total number of shares of our common stock outstanding on December 31 of the prior calendar year, or a lesser number of shares determined by our board of directors. The shares reserved include only the outstanding shares related to stock options and RSUs, and excludes stock options outstanding under the Original Plan. The number of shares reserved for issuance under the New Plan are 12,926,172 shares, effective as of January 1, 2019.

For the year ended December 31, 2018, the total stock-based compensation expense associated with the New Plan was $20,629. As at December 31, 2017, no stock options, RSUs or restricted stock awards were granted under the New Plan.

The fair value of each stock option granted to employees under the New Plan is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:

	Assumptions 2018
Expected stock option life (years)	5.79 years
Expected volatility		58.54	%
Risk-free interest rate		2.92	%
Expected dividend yield		-	%

The expected life of the awards represents the period of time stock options are expected to be outstanding and is estimated considering vesting terms and employees’ historical exercise and post-vesting employment termination behavior. Expected volatility is based on historical volatilities of public companies operating in a similar industry to the Company. A forfeiture rate is estimated at the time of grant to reflect the amount of awards that are granted but are expected to be forfeited by the award holder prior to vesting. The estimated forfeiture rate applied to these amounts is derived from management’s estimate of the future stock option forfeiture behavior over the expected life of the awards. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant.

Stock option and RSU activity for the Company under the New Plan is as follows:

Time-based stock option activity

	Stock Options			Weighted- average exercise price		Weighted-average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2017		—		$	—			$	—
Granted		6,106,011			13.66				—
Exercised		—			—				—
Forfeited		(90,970	)		21.49				—
Cancelled		—			—				—
Balance December 31, 2018		6,015,041		$	13.54		7.7	$	342,916
Vested and expected to vest, December 31, 2018		5,708,817		$	13.54		9.4	$	326,567
Vested and exercisable, December 31, 2018		1,312,500		$	7.76		9.4	$	82,399

The weighted-average fair values of all time-based stock options granted in 2018 was $7.74 per share. As of December 31, 2018, the total remaining unrecognized compensation expense related to non-vested stock options amounted to $38,250, which will be amortized over the weighted-average remaining requisite service period of approximately 2.8 years. The total fair value of stock options vested in 2018 were $5,508.

Performance-based stock option activity

	Stock Options		Weighted- average exercise price		Weighted-average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2017		—	$	—			$	—
Granted		600,000		7.76				—
Exercised		—		—				—
Forfeited		—		—				—
Cancelled		—		—				—
Balance December 31, 2018		600,000	$	7.76		9.4	$	37,668
Vested and expected to vest, December 31, 2018		591,486	$	7.76		9.4	$	37,134
Vested and exercisable, December 31, 2018		300,000	$	7.76		9.4	$	18,834

The weighted-average fair values of all performance-based stock options granted in 2018 was $4.15 per share. As of December 31, 2018, the total remaining unrecognized compensation expense related to non-vested stock options amounted to $593, which will be amortized over the weighted-average remaining requisite service period of approximately 0.6 years. The total fair value of stock options vested in 2018 were $1,246.

Time-based RSU activity

The following table summarizes non-vested time-based RSU activity during 2018:

	Time-based RSUs			Weighted-average grant-date fair value per share
Non-vested December 31, 2017		—		$	—
Granted		238,082			50.08
Exercised		—			—
Forfeited		(860	)		110
Non-vested December 31, 2018		237,222		$	49.86

As of December 31, 2018, there was approximately $10,336 of total unrecognized compensation cost related to non-vested time-based RSUs that will be recognized as expense over a weighted-average period of 3.17 years. No time-based RSUs vested during the period.

Performance-based RSUs

The following table summarizes non-vested performance-based RSU activity during 2018:

	Performance-based RSUs		Weighted-average grant-date fair value per share
Non-vested December 31, 2017		—	$	—
Granted		1,050,000		7.76
Exercised		—		—
Forfeited		—		—
Non-vested December 31, 2018		1,050,000	$	7.76

As of December 31, 2018, there was approximately $1,882 of total unrecognized compensation cost related to non-vested performance-based RSUs that will be recognized as expense over a weighted-average period of 1.73 years. No performance-based RSUs vested during the period.

Income Taxes

12 Months Ended

Dec. 31, 2018

Income Tax Disclosure [Abstract]

Income Taxes

14. Income Taxes

In connection with the Convertible Notes issued in 2018, we recognized a deferred tax liability of $8,809 in equity. As a result, we recorded an income tax benefit of $4,485 for the release of a valuation allowance on our existing U.S. deferred tax assets in order to offset the deferred tax liability established for the equity portion of the Convertible Notes. We recorded a deferred tax liability of $100 resulting from the purchase price allocation for Alef. We have net deferred tax assets which are fully offset by a valuation allowance due to our determination that it is more likely than not that the deferred tax assets will not be realized, with the exception of deferred tax assets that were applied to offset the deferred tax liability on the equity portion of the Convertible Notes. The realization of deferred tax assets is dependent on the Company generating sufficient taxable income in the years that the temporary differences become deductible. A valuation allowance has been provided for the portion of the deferred tax assets that the Company determined is more likely than not to remain unrealized based on estimated future taxable income. In the event we were to determine that we would be able to realize our net deferred tax assets in the future, an adjustment to the valuation allowance will be made, which will increase income (or decrease losses) in the period in which such a determination is made. We follow the guidance related to accounting for uncertainty in income taxes, which requires the recognition of an uncertain tax position provision when the position is not more likely than not to be sustainable upon audit by the applicable taxing authority

For financial reporting purposes, loss before income taxes includes the following components:

	Year ended December 31,
	2018			2017			2016
Canada	$	(25,333	)	$	(7,411	)	$	(7,883	)
U.S.		(42,418	)		—			—
Portugal		(2,208	)		—			—
Other countries		(2,215	)		(398	)		—
Total	$	(72,174	)	$	(7,809	)	$	(7,883	)

The expense for income taxes consists of:

	Year ended December 31,
	2018			2017		2016
Current:
Canada	$	—		$	—	$	—
Other countries		34			—		—
Total	$	34		$	—	$	—

Deferred:
Canada	$	—		$	—	$	—
U.S.		(4,485	)		—		—
Total	$	(4,485	)	$	—	$	—

Income tax expense in 2018 was related to taxable profit in Germany. The income tax benefit in 2018 was related to the release valuation allowance for deferred tax assets recognized to offset the deferred tax liability recorded for the Convertible Notes.

We recognized interest and penalties related to unrecognized tax benefits on the income tax expense line in the accompanying Consolidated Statements of Net Loss and Comprehensive Loss. Accrued interest and penalties are included on the related tax liability line in the Consolidated Balance Sheets.

Reconciliation of the expected income tax at the United States statutory income tax rate of 21% (2017 – 35%) to income tax expense:

	Year ended December 31,
	2018			2017			2016
Loss before income taxes:	$	(72,174	)	$	(7,809	)	$	(7,883	)
Expected income tax recovery		(15,157	)		(2,733	)		(2,797	)
Difference in foreign tax rates		(1,864	)		675			719
Foreign exchange and other		1,399			(480	)		(72	)
Non-deductible expenses		5,331			61			(40	)
Changes in enacted rates		—			(288	)		—
Utilization of losses no previously recognized		—			(9	)		—
Change in valuation allowance		5,840			2,774			2,190
Income tax recovery, net	$	(4,451	)	$	—		$	—

The following table summarizes the components of deferred tax:

	Year ended December 31,
	2018			2017			2016
Deferred assets
Tax loss carryforwards – Canada	$	13,723		$	8,297		$	5,821
Tax loss carryforwards – U.S.		4,173			—			—
Tax loss carryforwards – other countries		607			148			9
Property and equipment		2,510			183			98
Deferred financing costs		27			37			—
Investment tax credits and related pool balance		57			57			57
Other		—			8			—
Total Deferred tax assets		21,097			8,730			5,985
Less valuation allowance		(14,433	)		(8,601	)		(5,836	)
Net deferred tax assets		6,664			129			149
Deferred tax liabilities
Plant and equipment		(2,328	)		—			—
Intangible assets		(289	)		(129	)		(144	)
Deferred financing costs		—			—			(5	)
Equity portion of convertible senior notes due 2023		(8,471	)		—			—
Total deferred tax liabilities		(11,088	)		(129	)		(149	)
Net deferred tax liability	$	(4,424	)	$	—		$	—

The realization of deferred tax assets is dependent on the Company generating sufficient taxable income in the years that the temporary differences become deductible. A valuation allowance has been provided for the portion of the deferred tax assets that the Company determined is more likely than not to remain unrealized based on estimated future taxable income.

As of December 31, 2018 and 2017, the Company had accumulated tax losses available to offset future years’ federal and provincial taxable income in Canada of approximately $51,064 and $30,000, respectively. The Canadian non-capital loss carryforwards expire as noted in the table below:

December 31,	Amount
2033	$	381
2034		6,429
2035		7,627
2036		7,230
2037		6,195
2038		23,202
	$	51,064

As of December 31, 2018, the Company has Australian net operating loss carryforward of $162 (2017 – $167). The loss may be carried forward indefinitely. The Company has Portuguese net operating loss of $2,538 (2017 – $74). Portuguese net operating loss carry forward 5 years and expire in 2023. The Company has U.S. net operating losses available to offset future years' taxable income in the U.S. approximately $19,872. The net operating loss can only offset 80% of taxable income and it may be carried forward indefinitely.

The Company files federal income tax returns in Canada, Germany, and other foreign jurisdictions. The Company has open tax years with various taxing jurisdictions. These open years contain certain matters that could be subject to differing interpretations of applicable tax laws and regulations, and tax treaties, as they relate to the amount, timing, or inclusion of revenue and expense.

Jurisdiction		Open Years
Netherlands		2016 - 2018
Canada		2014 - 2018
Germany		2016 - 2018
Australia		2017 - 2018
Portugal		2017 - 2018

Tilray Canada, Ltd. is currently under examination by the Canada Revenue Agency for the 2014 and 2015 taxation years.

The following table outlines the movements in the valuation allowance:

Balance at

beginning

of year

Change due to

expense and

foreign

exchange

Deductions

Balance at

end of year

Year ended December 31, 2018

8,601

(113

)

5,945

14,433

Year ended December 31, 2017

5,836

395

2,370

8,601

The valuation allowance increased by $5,832 in 2018, increased by $2,765 in 2017, which was mostly related to the changes in our deferred tax asset balances. The 2018 increase in the valuation allowance was due to $10,317 related to the current year loss, tax credits, foreign exchange and other activity, offset by $4,485 decrease for release of valuation allowance related to the deferred tax liabilities charged to equity.

Commitments and Contingencies

12 Months Ended

Dec. 31, 2018

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

15. Commitments and Contingencies

Legal proceedings

In the normal course of business, the Company may become involved in legal disputes regarding various litigation matters. In the opinion of management, any potential liabilities resulting from such claims would not have a material effect on the financial statements.

Lease commitments

The Company leases various facilities, under non-cancelable capital and operating leases, which expire at various dates through September 2027.

Under the terms of the operating lease agreements, the Company is responsible for certain insurance and maintenance expenses. The Company records rent expense on a straight-line basis over the terms of the underlying leases. Rent expense for the year ended December 31, 2018 was $745 (2017 – $175 and 2016 – $0).

In February 2018, High Park Holdings, Ltd. entered into an operating lease to finance its expansion of production operations in London, Ontario, Canada.

Aggregate future minimum rental payments under all non-cancelable capital and operating leases are as follows:

	Operating Leases				Capital Leases
	December 31,				December 31,
	2018		2017		2018		2017
2019	$	916	$	46	$	733	$	772
2020		857		15		733		772
2021		727		—		733		772
2022		589		—		733		772
2023		510		—		183		579
Thereafter		1,372		—		—		—
	$	4,971	$	61	$	3,115	$	3,667

Purchase commitments

In December 2018, the Company signed an agreement with Rose Lifescience, Inc., for distribution and marketing of the Company’s product in Quebec in exchange for minimum fees of $500 per annum for an initial term of five years.

Acquisitions

12 Months Ended

Dec. 31, 2018

Business Combinations [Abstract]

Acquisitions

16. Acquisitions

Acquisition of Alef

In October 2018, the Company acquired Alef, a privately held company, which is an existing import and distribution partner. With this acquisition, the Company expanded its reach to the South American markets, and is now Tilray Latin America, a subsidiary of Tilray, Inc. The total consideration paid was $2,893, comprising of $2,855 of Company’s Class 2 common stock, of which $736 is held in escrow and cash consideration of $38.

The transaction was accounted for as an asset acquisition, as it did not constitute a business as defined in ASC 805 Business Combinations. The escrow consideration has not been released as of the issuance date of these financial statements because the 12 months have not elapsed. The Company notes that the cost of a group of assets acquired in an asset acquisition shall be allocated to the individual assets acquired or liabilities assumed based on their relative fair values. Part of the asset acquisition included Alef’s cannabis license, $2,984, which has been recognized as intangible asset.

The consideration includes a contingent component based upon the achievement of certain milestones. The contingent consideration will be recognized when the milestones will be reached.

Financial Instruments

12 Months Ended

Dec. 31, 2018

Investments All Other Investments [Abstract]

Financial Instruments

17. Financial Instruments

Credit risk

Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations, and arises principally from the Company’s cash and cash equivalents, accounts receivable and short-term investments.

The Company’s cash and cash equivalents are deposited in major financial institutions in Canada, Australia, Portugal, Germany, Netherlands and the United States. To date, the Company has not experienced any losses on its cash deposits. Accounts receivable are unsecured and the Company does not require collateral from its customers.

The Company is also exposed to credit risk from the potential default by any of its counterparties on its financial assets.

The Company evaluates the collectability of its accounts receivable and provides an allowance for potential credit losses as necessary. As at December 31, 2018 and December 31, 2017, the Company is not exposed to any significant credit risk related to counterparty performance of outstanding accounts receivable.

Foreign currency risk

As the Company conducts its business in many areas of the world involving transactions denominated in a variety of currencies, the Company is exposed to foreign currency risk. A significant portion of the Company’s assets, revenue, and expenses are denominated in the Canadian dollar. A 10% change in the exchange rates for the Canadian dollar would affect the carrying value of net assets by approximately $2,817 as of December 31, 2018, with a corresponding impact to accumulated other comprehensive income. As at December 31, 2018 the Company had foreign currency loss (gain), net of $7,234. This amount was primarily related to the translation of cash and cash equivalents and short-term investments on the Consolidated Balance Sheets.

Liquidity risk

The Company’s objective is to have sufficient liquidity to meet its liabilities when due. The Company monitors its cash balances and cash flows generated from operations to meet its requirements. As at December 31, 2018 and December 31, 2017, the most significant financial liabilities are acconts payable and debt facilities due to Privateer Holdings, Convertible Senior Notes Due 2023, current portion of long-term debt and accounts payable and accrued liabilities.

Related Party Transactions

12 Months Ended

Dec. 31, 2018

Related Party Transactions

18. Related-Party Transaction

In the normal course of business, the Company enters into related party transactions with Privateer Holdings and its subsidiaries, including certain debt facilities and charge for services provided by executives and employees of Privateer Holdings.

The various components of the Privateer Holdings debt facilities which represents the related-party balances outstanding are as follows:

	As of December 31,
	2018		2017
Privateer Holdings credit facility	$	—	$	24,700
Privateer Holdings construction facility		—		6,395
Privateer Holdings start-up loans		—		1,731
Total	$	—	$	32,826

Privateer Holdings credit facility

Effective January 1, 2016, Tilray Canada, Ltd. entered into an agreement with Privateer Holdings for a demand revolving credit facility in an aggregate principal amount not to exceed $25,000. As of December 31, 2017, the facility bore interest at a floating rate of 2.54%, reset annually based on the mid-term applicable federal U.S. rate.

Effective April 1, 2018, Tilray, Inc. entered into an agreement with Privateer Holdings for a demand revolving credit facility in an aggregate principal amount not to exceed $7,000. The facility bears interest at a floating rate of 2.62%. The interest rate resets annually based on the mid-term applicable federal U.S. rate.

For the fiscal year ended December 31, 2018, the Company recognized $567 (2017 – $548 and 2016 – $992) in interest expense related to the Privateer Holdings credit facility.

Privateer Holdings construction facilities:

High Park Farms, Ltd. construction facility

Effective November 1, 2017, High Park Farms, Ltd. entered into an agreement with Privateer Holdings for a demand revolving construction facility in an aggregate principal amount not to exceed $10,000 to be used for the construction of its facility in Enniskillen, Ontario, Canada. Beginning January 1, 2018, the facility bears interest at a floating rate of 2.54%, reset annually based on the mid-term applicable federal U.S. rate.

Tilray Canada, Ltd. construction facility

Effective December 1, 2017, Tilray Canada Ltd. entered into an agreement with Privateer Holdings for a demand construction facility of $1,000. The proceeds of the facility were to be used to fund capital expenditures for Tilray Canada, Ltd. and its affiliated company, High Park Farms, Ltd. Beginning January 1, 2018, the facility bears interest at a floating rate of 2.54%, reset annually based on the mid-term applicable federal U.S. rate.

Privateer Holdings start-up loans

As part of the Company’s strategic initiatives to expand into additional geographic locations, Privateer Holdings provided the Company with initial working capital funding in the form of non-interest-bearing loans. The advances are repayable upon demand. The outstanding balances under these loans are:

	Year ended December 31,
	2018		2017
Tilray Deutschland GmbH	$	—	$	1,340
Tilray Portugal Unipessoal, Lda.		—		105
Other		—		286
	$	—	$	1,731

In July 2018, the Company repaid $36,940 of the outstanding Privateer Holdings debt facility, which included repayment of the Privateer Holdings credit facility, Privateer Holdings construction facility and the Privateer Holdings start-up loans.

Privateer Holdings management services

Prior to the repayment of the credit facility, accrued management fees charged by Privateer Holdings for services performed, including management services, support services, business development services and research and development services were included in the credit facility and reported within Privateer Holdings debt facility. Following the repayment of the credit facilities, and due to the change in nature of the relationship with Privateer Holdings, management services are reported under accounts payable. Management services owed to Privateer Holdings in accounts payable during the year ended December 31, 2018 was $3,878 (2017 – $3,397) and were included in operating expenses.

Amounts for the provision of management and support services are charged at cost based on the compensation of the respective employees of Privateer Holdings, which is estimated from the time devoted to the Company. Business development and research and development services are charged at cost plus a 9% markup. In February 2018, the Company entered into an agreement with Privateer Holdings, pursuant to which Privateer Holdings provides the Company with certain general administrative and corporate services on an as-requested basis. Pursuant to this agreement, the Company pays Privateer Holdings a monthly services fee that is based on the proportional share of the actual costs incurred by Privateer Holdings in performing the requested services. Personnel compensation is charged at cost plus a 3.0% markup and other services provided are charged at cost. The interest on the management services fee accrues at a floating rate of 2.54%, reset annually based on the mid-term applicable federal U.S. rate.

Leafly Holdings, Inc. (“Leafly”) operational expenses

The Company pays on behalf of Leafly, previously a wholly owned subsidiary of Privateer Holdings, certain operational expenses and vice-versa. These payments are then recharged to company that incurred the expense. Such payments made during the year are deemed immaterial.

Docklight LLC (“Docklight”) royalty and management services

The Company pays Docklight, previously a wholly owned subsidiary of Privateer Holdings, a royalty fee for using their branding on company products. The royalty fees paid during the year are deemed immaterial. Additionally, the Company receives management services from Docklight, for which the Company is charged management fees. The management service fees paid during the year are deemed immaterial.

Business Segment Information

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Business Segment Information

19. Business Segment Information

Segment reporting is prepared on the same basis that the Company’s Chief Executive Officer, who is the Company’s Chief Operating Decision Maker, manages the business, makes operating decisions and assesses performance. Management has determined that the Company operates in one segment: the development and sale of cannabis products.

Sources of revenues were as follows:

	Year Ended December 31,
	2018		2017		2016
Dried Cannabis	$	21,674	$	16,260	$	11,324
Cannabis extracts		21,179		3,965		1,107
Accessories and other		277		313		213
Total	$	43,130	$	20,538	$	12,644

Revenues attributed to a geographic region based on the location of the customer were as follows:

	Year Ended December 31,
	2018		2017		2016
Canada	$	40,209	$	19,775	$	12,644
Other countries		2,921		763		—
Total	$	43,130	$	20,538	$	12,644

Long-lived assets consisting of property and equipment, net of accumulated depreciation, attributed to geographic regions based on their physical location were as follows:

	December 31,
	2018		2017
Canada	$	64,687	$	39,086
Portugal		15,455		—
Other countries		72		899
Total	$	80,214	$	39,985

Major Customers

The company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than than 10% of the Company’s annual revenues and greater than 10% of accounts receivable as noted below.

We had one customer that accounted for 24% of our revenue for the year ended December 31, 2018. No one customer accounted for greater than 10% of our revenue in 2017 or 2016, respectively.

We had two customers that accounted for 16% and 30% of our accounts receivable balance as of December 31, 2018. No one customer accounted for greater than 10% of our accounts receivable in 2017.

Quarterly Financial Data (unaudited)

12 Months Ended

Dec. 31, 2018

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Data (unaudited)

20. Quarterly Financial Data (unaudited)

The following table contains selected quarterly data for 2018 and 2017. The information should be read in conjunction with the Company’s financial statements and related notes included elsewhere in this report. The Company believes that the following information reflects all normal recurring adjustments necessary for a fair presentation of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period.

Quarterly Financial Data (in thousands, except per share data):

	Three months ended
	March 31,			June 30,			September 30,			December 31,
2018
Revenue	$	7,808		$	9,744		$	10,047		$	15,531
Gross Margin		3,896			4,177			3,068			3,134
Operating Loss		(3,740	)		(10,990	)		(20,012	)		(22,908	)
Net loss		(5,181	)		(12,833	)		(18,699	)		(31,010	)
Net loss per share—basic and diluted	$	(0.07	)	$	(0.17	)	$	(0.21	)	$	(0.33	)
2017
Revenue	$	5,027		$	4,992		$	5,406		$	5,113
Gross Margin		2,768			2,708			2,967			2,934
Operating Loss		(388	)		(2,316	)		(2,182	)		(2,612	)
Net loss		(679	)		(2,435	)		(1,767	)		(2,928	)
Net loss per share—basic and diluted	$	(0.01	)	$	(0.01	)	$	(0.02	)	$	(0.04	)

Subsequent Events

12 Months Ended

Dec. 31, 2018

Subsequent Events [Abstract]

Subsequent Events

21. Subsequent Events

Acquisitions

In February 2019, the Company acquired all issued and outstanding shares of FHF Holdings Ltd. (“Manitoba Harvest”), a hemp and natural foods producer based in Winnipeg, Manitoba, for up to $319,000 ($419,000 CAD), subject to certain revenue milestones. Manitoba Harvest distributes its products to over 16,000 retail locations in the U.S. and Canada. The acquisition will expand the Company’s product portfolio into the natural foods category and bring Manitoba Harvest’s expertise in working with cannabinoids, including cannabidiol (CBD), to Tilray. Given the timing of the transaction, the Company is in process of determining our estimate of fair value and purchase price allocation.

In February 2019, the Company acquired all issued and outstanding shares of Natura Naturals Holdings Inc. (“Natura”) for up to $53,400 ($70,000 CAD), subject to certain cultivation miletones. Natura, through a wholly owned subsidiary located in Leamington, Ontario, is a licensed cultivator under the Cannabis Act specializing in the greenhouse cultivation and will increase the Company’s cannabis supply. Given the timing of the transaction, the Company is in process of determining our estimate of fair value and purchase price allocation.

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2018

Accounting Policies [Abstract]

Basis of Presentation

Basis of presentation

Basis of consolidation

These financial statements include the accounts of the following entities wholly owned by the Company as of December 31, 2018:


Name of entity	Date of formation	Place of incorporation
Tilray Canada, Ltd.	September 6, 2013	British Columbia, Canada
Dorada Ventures, Ltd.	October 18, 2013	British Columbia, Canada
High Park Farms, Ltd.	February 19, 2016	British Columbia, Canada
Tilray Deutschland GmbH	November 3, 2016	Germany
Tilray Portugal Unipessoal, Lda.	April 5, 2017	Portugal
Pardal Holdings, Lda.	April 24, 2017	Portugal
Tilray Australia New Zealand Pty. Ltd.	May 9, 2017	Australia
High Park Holdings, Ltd.	February 8, 2018	British Columbia, Canada
National Cannabinoid Clinics Pty Ltd.	September 19, 2018	Australia
Tilray Latin America SpA	November 5, 2018	Chile
Tilray Portugal II, Lda.	December 11, 2018	Portugal

Uses of Estimates

Use of estimates

Foreign Currency

Foreign currency

Net loss per share

Cash and Cash Equivalents

Cash and cash equivalents

Cash and cash equivalents are comprised of cash and highly liquid investments that are readily convertible into known amounts of cash with original maturities of three months or less.

Investments

Available-for-sale securities

Net realized gains and losses on investments are determined in accordance with the specific identification method.

Cost method investments

Equity securities for which the fair value is not readily determinable are carried at cost. Distributions from the equity security are recognized as income dividend when received.

An impairment charge is recorded if the carrying amount of the investment exceeds its fair value and determined to be other-than-temporary.

Fair Value Measurements

Fair value measurements

Inventory

Property and Equipment

Property and equipment

Intangible Assets

Intangible assets

The estimated useful lives are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis.

Impairment of Long-lived Assets

Impairment of long-lived assets

Capitalization of Interest

Capitalization of interest

Leases

Convertible Senior Notes due 2023

Revenue recognition

Cost of Sales

Cost of sales

Stock-based Compensation

Stock-based compensation

Income Taxes

Income taxes

New Accounting Pronouncements Not Yet Adopted

New accounting pronouncements not yet adopted

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2018

Accounting Policies [Abstract]

Schedule of Consolidated Entity

Basis of consolidation

These financial statements include the accounts of the following entities wholly owned by the Company as of December 31, 2018:


Name of entity	Date of formation	Place of incorporation
Tilray Canada, Ltd.	September 6, 2013	British Columbia, Canada
Dorada Ventures, Ltd.	October 18, 2013	British Columbia, Canada
High Park Farms, Ltd.	February 19, 2016	British Columbia, Canada
Tilray Deutschland GmbH	November 3, 2016	Germany
Tilray Portugal Unipessoal, Lda.	April 5, 2017	Portugal
Pardal Holdings, Lda.	April 24, 2017	Portugal
Tilray Australia New Zealand Pty. Ltd.	May 9, 2017	Australia
High Park Holdings, Ltd.	February 8, 2018	British Columbia, Canada
National Cannabinoid Clinics Pty Ltd.	September 19, 2018	Australia
Tilray Latin America SpA	November 5, 2018	Chile
Tilray Portugal II, Lda.	December 11, 2018	Portugal

Investments (Tables)

12 Months Ended

Dec. 31, 2018

Summary of Equity Investments

The following table provides a summary of the classification of our investment in equities:

	December 31,
	2018		2017
Investments in equities under available-for-sale method	$	1,845	$	—
Investment in equities under the cost method		15,066		—
Total investment in equities	$	16,911	$	—

Short-term Investments [Member]

Summary of Available for Sale Securities

The following table summarizes the unrealized gains and losses and estimated fair value of our short-term investments as of December 31, 2018:

Cost

Gross

unrealized

gains

Gross

unrealized

losses

Fair

value

Treasury bills

30,367

30,335

Total

30,367

30,335

Long-term Investments [Member]

Summary of Available for Sale Securities

The following table summarizes the unrealized gains and losses and estimated fair value of our long-term investments as of December 31, 2018:

Cost

Gross

unrealized

gains

Gross

unrealized

losses

Fair

value

Investment in equities

17,713

—

802

16,911

Total

17,713

—

802

16,911

Fair Value Measurement (Tables)

12 Months Ended

Dec. 31, 2018

Fair Value Disclosures [Abstract]

Schedule of Assets Measured Fair Value on Recurring Basis

	Quoted prices in active markets for identical assets (Level 1)		Other observable inputs (Level 2)		Significant unobservable inputs (Level 3)		Total
December 31, 2018
Cash equivalents:
Money market fund	$	33,111	$	—		—	$	33,111
Corporate bonds		7,796		—		—		7,796
Commercial paper		9,975		—		—		9,975
Treasury bills		152,879		—		—		152,879
Total cash equivalents		203,761		—		—		203,761
Investments:
Treasury bills		30,335		—		—		30,335
Investment in equities		1,163		682		—		1,845
Total investments		31,498		682		—		32,180
Total	$	235,259	$	682	$	—	$	235,941

Inventory (Tables)

12 Months Ended

Dec. 31, 2018

Inventory Disclosure [Abstract]

Schedule of Inventory

Inventory is comprised of the following items:

	December 31,
	2018		2017
Raw materials	$	2,132	$	163
Work-in-process – dry cannabis		9,982		1,396
Work-in-process – cannabis extracts		2,830		30
Finished goods – dry cannabis		113		3,501
Finished goods – cannabis extracts		1,083		2,158
Finished goods – accessories		71		173
Total	$	16,211	$	7,421

Property and Equipment, Net (Tables)

12 Months Ended

Dec. 31, 2018

Property Plant And Equipment [Abstract]

Summary of Property and Equipment

Property and equipment, net consisted of the following:

	December 31,
	2018			2017
Land	$	4,498		$	2,547
Buildings and leasehold improvements		51,111			19,569
Laboratory and manufacturing equipment		6,131			2,815
Office and computer equipment		970			571
Assets under capital lease		9,661			9,191
Construction in process		15,343			9,872
		87,714			44,565
Less: accumulated depreciation and amortization		(7,500	)		(4,580	)
Total	$	80,214		$	39,985

Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2018

Goodwill And Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

Intangible assets are comprised of the following items:

			December 31,
			2018						2017
	Weighted Average Amortization Period (in years)		Cost		Accumulated Amortization		Net		Cost		Accumulated Amortization		Net
Amortizing intangible assets:
Website		3	$	3,755	$	2,253	$	1,502	$	2,813	$	1,879	$	934
Total				3,755		2,253		1,502		2,813		1,879		934
Other intangible assets:
Alef license		—		2,984		—		2,984		—		—		—
Total				2,984		—		2,984		—		—		—
Total intangible assets			$	6,739	$	2,253	$	4,486	$	2,813	$	1,879	$	934

Accounts Payable and Accrued Expenses (Tables)

12 Months Ended

Dec. 31, 2018

Payables And Accruals [Abstract]

Schedule of Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses are comprised of the following items:

	December 31,
	2018		2017
Accounts payable - trade	$	9,716	$	5,563
Accounts payable - related parties		933		—
Accrued interest on convertible senior notes due 2023		5,302		—
Accrued legal fees		565		10
Accrued payroll		3,278		610
Other accrued expenses		5,673		1,401
Total	$	25,467	$	7,584

Long-Term Debt (Tables)

12 Months Ended

Dec. 31, 2018

Debt Disclosure [Abstract]

Summary of Long-Term Debt

Long-term debt is as follows:

	December 31,
	2018		2017
Mortgage payable, due January 2019, annual interest 11.5%	$	—	$	9,537
Unamortized deferred financing costs		—		(105	)
		—		9,432
Less current portion of long-term debt		—		(9,432	)
Total	$	—	$	—

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Convertible Senior Notes Due 2023 (Tables)

12 Months Ended

Dec. 31, 2018

Debt Disclosure [Abstract]

Schedule of Components of Net Carrying Amount of Convertible Notes

The following table sets forth the net carrying amount of the Convertible Notes:

	December 31, 2018
5.00% Convertible Senior Notes	$	475,000
Unamortized discount		(41,687	)
Unamortized transaction costs		(12,946	)
Net carrying amount	$	420,367

Schedule of Interest Expense Related to Convertible Notes

The following table sets forth total interest expense recognized related to the Convertible Notes:

	Year ended December 31, 2018
Contractual coupon interest	$	5,302
Amortization of discount		2,152
Amortization of direct issue costs		28
Total	$	7,482

Capital Stock (Tables)

12 Months Ended

Dec. 31, 2018

Equity [Abstract]

Summary of Capital Stock

The Company’s certificate of incorporation authorized the Company to issue the following classes of shares with the following par value and voting rights as of December 31, 2018.

	Par Value		Authorized		Voting Rights
Class 1 common stock	$	0.0001		250,000,000	10 votes for each share
Class 2 common stock	$	0.0001		500,000,000	1 vote for each share
Convertible preferred stock	$	0.0001		10,000,000	N/A

- Definition

Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(d))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644

Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

General and Administrative Expenses (Tables)

12 Months Ended

Dec. 31, 2018

General And Administrative Expense [Abstract]

Schedule of General and Administrative Expenses

General and administrative expenses are comprised of the following items:

	Year ended December 31,
	2018		2017		2016
Salaries	$	11,721	$	3,717	$	2,640
Professional fees		7,557		1,715		424
Travel expenses		2,031		287		109
Depreciation and amortization		1,598		902		591
Other expenses		8,400		1,780		1,126
Total	$	31,307	$	8,401	$	4,890

Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2018

Original Stock Option Plan [Member]

Weighted Average Fair Value Assumptions

	2018			2017			2016
Expected stock option life	5.15 years			5.84 years			6.05 years
Expected volatility		48.82	%		56.23	%		63.32	%
Risk-free interest rate		2.35	%		2.01	%		1.46	%
Expected dividend yield		-	%		-	%		-	%

Schedule of Stock Option Activity

Stock option activity for the Company under the Original Plan is as follows:

	Stock Options			Weighted- average exercise price		Weighted-average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2017		364,571		$	2.41		7.9	$	1,185
Granted		304,942			5.92
Exercised		(45,688	)		1.81
Forfeited		(25,881	)		5.14
Cancelled		(5,350	)		3.29
Balance December 31, 2018		592,594		$	4.14		8.1	$	989
Vested and expected to vest, December 31, 2018		522,301		$	3.94		8.0	$	955
Vested and exercisable, December 31, 2018		286,393		$	2.85		7.2	$	805

2018 Equity Incentive Plan [Member]

Weighted Average Fair Value Assumptions

	Assumptions 2018
Expected stock option life (years)	5.79 years
Expected volatility		58.54	%
Risk-free interest rate		2.92	%
Expected dividend yield		-	%

2018 Equity Incentive Plan [Member] | Time-based Stock Options [Member]

Schedule of Stock Option Activity

Time-based stock option activity

	Stock Options			Weighted- average exercise price		Weighted-average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2017		—		$	—			$	—
Granted		6,106,011			13.66				—
Exercised		—			—				—
Forfeited		(90,970	)		21.49				—
Cancelled		—			—				—
Balance December 31, 2018		6,015,041		$	13.54		7.7	$	342,916
Vested and expected to vest, December 31, 2018		5,708,817		$	13.54		9.4	$	326,567
Vested and exercisable, December 31, 2018		1,312,500		$	7.76		9.4	$	82,399

2018 Equity Incentive Plan [Member] | Performance-based Stock Options [Member]

Schedule of Stock Option Activity

Performance-based stock option activity

	Stock Options		Weighted- average exercise price		Weighted-average remaining contractual term (years)		Aggregate intrinsic value
Balance December 31, 2017		—	$	—			$	—
Granted		600,000		7.76				—
Exercised		—		—				—
Forfeited		—		—				—
Cancelled		—		—				—
Balance December 31, 2018		600,000	$	7.76		9.4	$	37,668
Vested and expected to vest, December 31, 2018		591,486	$	7.76		9.4	$	37,134
Vested and exercisable, December 31, 2018		300,000	$	7.76		9.4	$	18,834

2018 Equity Incentive Plan [Member] | Time-based RSU [Member]

Schedule of RSU Activity

Time-based RSU activity

The following table summarizes non-vested time-based RSU activity during 2018:

	Time-based RSUs			Weighted-average grant-date fair value per share
Non-vested December 31, 2017		—		$	—
Granted		238,082			50.08
Exercised		—			—
Forfeited		(860	)		110
Non-vested December 31, 2018		237,222		$	49.86

2018 Equity Incentive Plan [Member] | Performance-based RSUs [Member]

Schedule of RSU Activity

Performance-based RSUs

The following table summarizes non-vested performance-based RSU activity during 2018:

	Performance-based RSUs		Weighted-average grant-date fair value per share
Non-vested December 31, 2017		—	$	—
Granted		1,050,000		7.76
Exercised		—		—
Forfeited		—		—
Non-vested December 31, 2018		1,050,000	$	7.76

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2018

Income Tax Disclosure [Abstract]

Summary of Loss Loss Before Income Taxes

For financial reporting purposes, loss before income taxes includes the following components:

	Year ended December 31,
	2018			2017			2016
Canada	$	(25,333	)	$	(7,411	)	$	(7,883	)
U.S.		(42,418	)		—			—
Portugal		(2,208	)		—			—
Other countries		(2,215	)		(398	)		—
Total	$	(72,174	)	$	(7,809	)	$	(7,883	)

Summary of Expense for Income Taxes

The expense for income taxes consists of:

	Year ended December 31,
	2018			2017		2016
Current:
Canada	$	—		$	—	$	—
Other countries		34			—		—
Total	$	34		$	—	$	—

Deferred:
Canada	$	—		$	—	$	—
U.S.		(4,485	)		—		—
Total	$	(4,485	)	$	—	$	—

Summary of Effective Income Tax Rate Reconciliation

Reconciliation of the expected income tax at the United States statutory income tax rate of 21% (2017 – 35%) to income tax expense:

	Year ended December 31,
	2018			2017			2016
Loss before income taxes:	$	(72,174	)	$	(7,809	)	$	(7,883	)
Expected income tax recovery		(15,157	)		(2,733	)		(2,797	)
Difference in foreign tax rates		(1,864	)		675			719
Foreign exchange and other		1,399			(480	)		(72	)
Non-deductible expenses		5,331			61			(40	)
Changes in enacted rates		—			(288	)		—
Utilization of losses no previously recognized		—			(9	)		—
Change in valuation allowance		5,840			2,774			2,190
Income tax recovery, net	$	(4,451	)	$	—		$	—

Summary of Components of Deferred Tax

The following table summarizes the components of deferred tax:

	Year ended December 31,
	2018			2017			2016
Deferred assets
Tax loss carryforwards – Canada	$	13,723		$	8,297		$	5,821
Tax loss carryforwards – U.S.		4,173			—			—
Tax loss carryforwards – other countries		607			148			9
Property and equipment		2,510			183			98
Deferred financing costs		27			37			—
Investment tax credits and related pool balance		57			57			57
Other		—			8			—
Total Deferred tax assets		21,097			8,730			5,985
Less valuation allowance		(14,433	)		(8,601	)		(5,836	)
Net deferred tax assets		6,664			129			149
Deferred tax liabilities
Plant and equipment		(2,328	)		—			—
Intangible assets		(289	)		(129	)		(144	)
Deferred financing costs		—			—			(5	)
Equity portion of convertible senior notes due 2023		(8,471	)		—			—
Total deferred tax liabilities		(11,088	)		(129	)		(149	)
Net deferred tax liability	$	(4,424	)	$	—		$	—

Summary of Canadian Non-Capital Loss Carryforwards

The Canadian non-capital loss carryforwards expire as noted in the table below:

December 31,	Amount
2033	$	381
2034		6,429
2035		7,627
2036		7,230
2037		6,195
2038		23,202
	$	51,064

Summary of Open Tax Years

Jurisdiction		Open Years
Netherlands		2016 - 2018
Canada		2014 - 2018
Germany		2016 - 2018
Australia		2017 - 2018
Portugal		2017 - 2018

Summary of Movements in Valuation Allowance

The following table outlines the movements in the valuation allowance:

Balance at

beginning

of year

Change due to

expense and

foreign

exchange

Deductions

Balance at

end of year

Year ended December 31, 2018

8,601

(113

)

5,945

14,433

Year ended December 31, 2017

5,836

395

2,370

8,601

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2018

Commitments And Contingencies Disclosure [Abstract]

Schedule of Future Minimum Rental Payments Under All Non-cancelable Capital and Operating Leases

Aggregate future minimum rental payments under all non-cancelable capital and operating leases are as follows:

	Operating Leases				Capital Leases
	December 31,				December 31,
	2018		2017		2018		2017
2019	$	916	$	46	$	733	$	772
2020		857		15		733		772
2021		727		—		733		772
2022		589		—		733		772
2023		510		—		183		579
Thereafter		1,372		—		—		—
	$	4,971	$	61	$	3,115	$	3,667

Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2018

Privateer Holdings Start Up Loans [Member]

The outstanding balances under these loans are:

	Year ended December 31,
	2018		2017
Tilray Deutschland GmbH	$	—	$	1,340
Tilray Portugal Unipessoal, Lda.		—		105
Other		—		286
	$	—	$	1,731

Privateer Holdings [Member]

The various components of the Privateer Holdings debt facilities which represents the related-party balances outstanding are as follows:

	As of December 31,
	2018		2017
Privateer Holdings credit facility	$	—	$	24,700
Privateer Holdings construction facility		—		6,395
Privateer Holdings start-up loans		—		1,731
Total	$	—	$	32,826

Business Segment Information (Tables)

12 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Summary of Sources of Revenue

Sources of revenues were as follows:

	Year Ended December 31,
	2018		2017		2016
Dried Cannabis	$	21,674	$	16,260	$	11,324
Cannabis extracts		21,179		3,965		1,107
Accessories and other		277		313		213
Total	$	43,130	$	20,538	$	12,644

Summary of Revenues Attributed to a Geographic Region Based on the Location of the Customer

Revenues attributed to a geographic region based on the location of the customer were as follows:

	Year Ended December 31,
	2018		2017		2016
Canada	$	40,209	$	19,775	$	12,644
Other countries		2,921		763		—
Total	$	43,130	$	20,538	$	12,644

Summary of Long-lived Assets Consisting of Property, Plant and Equipment, Net of Accumulated Depreciation, Attributed to Geographic Regions Based on their Physical Location

Long-lived assets consisting of property and equipment, net of accumulated depreciation, attributed to geographic regions based on their physical location were as follows:

	December 31,
	2018		2017
Canada	$	64,687	$	39,086
Portugal		15,455		—
Other countries		72		899
Total	$	80,214	$	39,985

Quarterly Financial Data (unaudited) (Tables)

12 Months Ended

Dec. 31, 2018

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Data

Quarterly Financial Data (in thousands, except per share data):

	Three months ended
	March 31,			June 30,			September 30,			December 31,
2018
Revenue	$	7,808		$	9,744		$	10,047		$	15,531
Gross Margin		3,896			4,177			3,068			3,134
Operating Loss		(3,740	)		(10,990	)		(20,012	)		(22,908	)
Net loss		(5,181	)		(12,833	)		(18,699	)		(31,010	)
Net loss per share—basic and diluted	$	(0.07	)	$	(0.17	)	$	(0.21	)	$	(0.33	)
2017
Revenue	$	5,027		$	4,992		$	5,406		$	5,113
Gross Margin		2,768			2,708			2,967			2,934
Operating Loss		(388	)		(2,316	)		(2,182	)		(2,612	)
Net loss		(679	)		(2,435	)		(1,767	)		(2,928	)
Net loss per share—basic and diluted	$	(0.01	)	$	(0.01	)	$	(0.02	)	$	(0.04	)

Description of Business and Summary - Additional Information (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2018 SUB	Dec. 31, 2016 USD ($)
Date of entity incorporation	Jan. 24, 2018
Place of entity incorporation	Delaware
Privateer Holdings [Member]
Parent entity name	Privateer Holdings, Inc. (“Privateer Holdings”)
Number of subsidiaries \| SUB	4
Capital contribution from parent \| $		$ 31,495

Summary of Significant Accounting Policies - Schedule of Consolidated Entity (Detail)	12 Months Ended
	Dec. 31, 2018
Accounting Policies [Line Items]
Date of entity incorporation	Jan. 24, 2018
Place of entity incorporation	Delaware
Tilray Canada, Ltd. [Member]
Accounting Policies [Line Items]
Date of entity incorporation	Sep. 06, 2013
Place of entity incorporation	British Columbia, Canada
Dorada Ventures, Ltd. [Member]
Accounting Policies [Line Items]
Date of entity incorporation	Oct. 18, 2013
Place of entity incorporation	British Columbia, Canada
High Park Farms Ltd [Member]
Accounting Policies [Line Items]
Date of entity incorporation	Feb. 19, 2016
Place of entity incorporation	British Columbia, Canada
Tilray Deutschland GmbH [Member]
Accounting Policies [Line Items]
Date of entity incorporation	Nov. 03, 2016
Place of entity incorporation	Germany
Tilray Portugal Unipessoal Lda [Member]
Accounting Policies [Line Items]
Date of entity incorporation	Apr. 05, 2017
Place of entity incorporation	Portugal
Pardal Holdings, Lda. [Member]
Accounting Policies [Line Items]
Date of entity incorporation	Apr. 24, 2017
Place of entity incorporation	Portugal
Tilray Australia New Zealand Pty. Ltd. [Member]
Accounting Policies [Line Items]
Date of entity incorporation	May 09, 2017
Place of entity incorporation	Australia
High Park Holdings, Ltd. [Member]
Accounting Policies [Line Items]
Date of entity incorporation	Feb. 08, 2018
Place of entity incorporation	British Columbia, Canada
National Cannabinoid Clinics Pty Ltd. [Member]
Accounting Policies [Line Items]
Date of entity incorporation	Sep. 19, 2018
Place of entity incorporation	Australia
Tilray Latin America SpA [Member]
Accounting Policies [Line Items]
Date of entity incorporation	Nov. 05, 2018
Place of entity incorporation	Chile
Tilray Portugal II, Lda. [Member]
Accounting Policies [Line Items]
Date of entity incorporation	Dec. 11, 2018
Place of entity incorporation	Portugal

Summary of Significant Accounting Policies - Additional Information (Detail) - shares	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Mar. 08, 2016
Accounting Policies [Line Items]
Antidilutive securities excluded from computation of earnings per share	7,902,263	0	0
Lease agreement description	The Company enters into various leases in conducting its business. At the inception of each lease, the Company evaluates the lease agreement to determine whether the lease is an operating or capital lease. A capital lease is a lease in which 1) ownership of the property transfers to the lessee by the end of the lease term; 2) the lease contains a bargain purchase option; 3) the lease term is equal to 75% or more of the economic life of the leased property; or 4) the present value of the minimum lease payment at the inception of the lease term equals or exceeds 90% of the fair value of the leased property
Building [Member]
Accounting Policies [Line Items]
Property, plant and equipment useful life	20 years
Maximum [Member]
Accounting Policies [Line Items]
Cash and cash equivalents maturity period	3 months
Property, plant and equipment useful life	7 years
Minimum [Member]
Accounting Policies [Line Items]
Property, plant and equipment useful life	3 years
Percentage of economic life of capital leased property	75.00%
Percentage of present value of capital leased payment at inception of lease term	90.00%
Privateer Holdings [Member]
Accounting Policies [Line Items]
Ownership interest				100.00%

Investments - Summary of Available for Sale Securities (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Available For Sale Securities [Line Items]
Available-for-sale securities, fair value	$ 16,911	$ 0
Short-term Investments [Member]
Schedule Of Available For Sale Securities [Line Items]
Available-for-sale securities, amortized costs	30,367
Available-for-sale securities, Gross unrealized gains	32
Available-for-sale securities, Gross unrealized losses	64
Available-for-sale securities, fair value	30,335
Short-term Investments [Member] \| Treasury Bills [Member]
Schedule Of Available For Sale Securities [Line Items]
Available-for-sale securities, amortized costs	30,367
Available-for-sale securities, Gross unrealized gains	32
Available-for-sale securities, Gross unrealized losses	64
Available-for-sale securities, fair value	30,335
Long-term Investments [Member]
Schedule Of Available For Sale Securities [Line Items]
Available-for-sale securities, amortized costs	17,713
Available-for-sale securities, Gross unrealized losses	802
Available-for-sale securities, fair value	16,911
Long-term Investments [Member] \| Investment in Equities [Member]
Schedule Of Available For Sale Securities [Line Items]
Available-for-sale securities, amortized costs	17,713
Available-for-sale securities, Gross unrealized losses	802
Available-for-sale securities, fair value	$ 16,911

Investments - Summary of Equity Investments (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Available For Sale Securities [Line Items]
Investment in equities	$ 16,911	$ 0
Cost Method of Accounting [Member]
Schedule Of Available For Sale Securities [Line Items]
Investment in equities	15,066
Available for sale method [Member]
Schedule Of Available For Sale Securities [Line Items]
Investment in equities	$ 1,845

Investments - Additional Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Schedule Of Available For Sale Securities [Line Items]
Short-term and long-term investments	$ 16,911	$ 0
Long-term Investments [Member]
Schedule Of Available For Sale Securities [Line Items]
Available-for-sale securities, Gross unrealized losses	802
Short-term and long-term investments	16,911
Long-term Investments [Member] \| Investment in Equities [Member]
Schedule Of Available For Sale Securities [Line Items]
Available-for-sale securities, Gross unrealized losses	802
Short-term and long-term investments	$ 16,911

Fair Value Measurement - Schedule of Assets Measured Fair Value on Recurring Basis (Detail) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total cash equivalents	$ 203,761
Total investments	32,180
Total	235,941	$ 0
Corporate Bonds [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total cash equivalents	7,796
Treasury Bills [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total cash equivalents	152,879
Total investments	30,335
Investment in Equities [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments	1,845
Level 1 [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total cash equivalents	203,761
Total investments	31,498
Total	235,259
Level 1 [Member] \| Corporate Bonds [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total cash equivalents	7,796
Level 1 [Member] \| Treasury Bills [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total cash equivalents	152,879
Total investments	30,335
Level 1 [Member] \| Investment in Equities [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments	1,163
Level 2 [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments	682
Total	682
Level 2 [Member] \| Investment in Equities [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total investments	682
Money Market Funds [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total cash equivalents	33,111
Money Market Funds [Member] \| Level 1 [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total cash equivalents	33,111
Commercial Paper [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total cash equivalents	9,975
Commercial Paper [Member] \| Level 1 [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Total cash equivalents	$ 9,975

Fair Value Measurement - Additional Information (Detail) - Fair Value, Measurements, Recurring [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Assets, Fair Value Disclosure	$ 235,941	$ 0
Unrealized gain recorded in other comprehensive income	$ 69

Inventory - Schedule of Inventory (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Inventory [Line Items]
Raw materials	$ 2,132	$ 163
Total	16,211	7,421
Dry Cannabis [Member]
Inventory [Line Items]
Work-in-process	9,982	1,396
Finished goods	113	3,501
Cannabis Extracts [Member]
Inventory [Line Items]
Work-in-process	2,830	30
Finished goods	1,083	2,158
Accessories [Member]
Inventory [Line Items]
Finished goods	$ 71	$ 173

Inventory - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Inventory [Line Items]
Inventory write-downs	$ 384	$ 204	$ 234
Cannabis Oil [Member]
Inventory [Line Items]
Inventory write-downs	$ 4,561	$ 617

Property and Equipment, Net - Summary of Property and Equipment (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 87,714	$ 44,565
Less: accumulated depreciation and amortization	(7,500)	(4,580)
Property and equipment, net	80,214	39,985
Land [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	4,498	2,547
Buildings and Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	51,111	19,569
Laboratory and Manufacturing Equipment [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	6,131	2,815
Office and Computer Equipment [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	970	571
Assets under Capital Lease [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	9,661	9,191
Construction in Process [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 15,343	$ 9,872

Property and Equipment, Net - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Construction in Process [Member]
Property Plant And Equipment [Line Items]
Capitalized interest	$ 158	$ 34
Cost of Sales [Member]
Property Plant And Equipment [Line Items]
Depreciation expense	1,964	1,303	$ 1,247
General and Administrative Expense [Member]
Property Plant And Equipment [Line Items]
Depreciation expense	$ 149	$ 95	$ 92

Intangible Assets - Schedule of Intangible Assets (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Acquired Finite Lived Intangible Assets [Line Items]
Finite lived intangible asset, Cost	$ 3,755	$ 2,813
Finite lived intangible asset, Accumulated Amortization	2,253	1,879
Finite lived intangible asset, Net	1,502	934
Indefinite intangible asset, Cost	2,984
Total intangible asset, Cost	6,739	2,813
Total intangible asset, Net	4,486	934
Alef License [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Indefinite intangible asset, Cost	$ 2,984
Website [Member]
Acquired Finite Lived Intangible Assets [Line Items]
Weighted Average Amortization Period (in years)	3 years
Finite lived intangible asset, Cost	$ 3,755	2,813
Finite lived intangible asset, Accumulated Amortization	2,253	1,879
Finite lived intangible asset, Net	$ 1,502	$ 934

Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Finite Lived Intangible Assets [Line Items]
Indefinite intangible asset, Cost	$ 2,984
Net carrying value of intangible assets	1,502	$ 934
Finite lived intangible assets amortization expense, 2019	731
Finite lived intangible assets amortization expense, 2020	431
Finite lived intangible assets amortization expense, 2021	340
Finite lived intangible assets amortization expense, thereafter	0
Additional Functionalities For Patient Portal [Member]
Finite Lived Intangible Assets [Line Items]
Net carrying value of intangible assets	43	$ 381
Alef License [Member]
Finite Lived Intangible Assets [Line Items]
Indefinite intangible asset, Cost	$ 2,984

Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Accounts Payable And Accrued Liabilities Current And Noncurrent [Abstract]
Accounts payable - trade	$ 9,716	$ 5,563
Accounts payable - related parties	933
Accrued interest on convertible senior notes due 2023	5,302
Accrued legal fees	565	10
Accrued payroll	3,278	610
Other accrued expenses	5,673	1,401
Total	$ 25,467	$ 7,584

Long-Term Debt - Summary of Long-term Debt (Detail) $ in Thousands	Dec. 31, 2017 USD ($)
Debt Instrument [Line Items]
Unamortized deferred financing costs	$ (105)
Long-term Debt	9,432
Less current portion of long-term debt	(9,432)
11.5% Mortgage Loan Payable Due January 2019 [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 9,537

Long-Term Debt - Summary of Long-term Debt (Parenthetical) (Detail) - 11.5% Mortgage Loan Payable Due January 2019 [Member]	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Debt instrument interest rate	11.50%	11.50%	11.50%
Debt instrument maturity period	Jan. 01, 2019	Jan. 01, 2019

Long-Term Debt - Additional Information (Detail) $ in Thousands, $ in Thousands	1 Months Ended	12 Months Ended
	Jul. 31, 2018 USD ($)	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016 USD ($)	Dec. 31, 2016 CAD ($)
Debt Instrument [Line Items]
Mortgage loan extended maturity date		Jan. 01, 2019
Mortgage loan extension renewal fees	$ 90
Mortgage loan extension renewal fees basis point	75.00%
11.5% Mortgage Loan Payable Due January 2019 [Member]
Debt Instrument [Line Items]
Debt instrument, face amount				$ 8,909	$ 12,000
Debt instrument interest rate		11.50%	11.50%	11.50%	11.50%

Convertible Senior Notes Due 2023 - Additional Information (Detail) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended
	Oct. 31, 2018 USD ($)	Dec. 31, 2018 USD ($) $ / shares	Dec. 31, 2016 USD ($)
Debt Instrument [Line Items]
Direct debt issuance costs			$ 359
Offering cost attributable to equity		$ 15,299
Convertible Senior Notes Due 2023
Debt Instrument [Line Items]
Debt instrument, face amount	$ 475,000	$ 475,000
Proceeds from issuance of debt	$ 460,134
Debt instrument interest payment term	The Convertible Notes bear interest at a rate of 5.00% per annum, payable semi-annually in arrears on April 1 and October 1 of each year, beginning on April 1, 2019.
Debt instrument interest rate	5.00%
Debt instrument maturity period	Oct. 01, 2023
Debt instrument, periodic payment of principal amount	$ 0
Debt instrument, term	5 years
Debt instrument, default condition		To the extent the Company so elects, the sole remedy for an event of default relating to certain failures by the Company to comply with certain reporting covenants in the Indenture will, for the first 365 days after such event of default, consist exclusively of the right to receive additional interest on the notes. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock, at the Company’s election (the “cash conversion option”)
Conversion rate of convertible notes		5.9735
Conversion price per share \| $ / shares		$ 167.41
Debt instrument convertible beneficial conversion feature	$ 57,600
Effective interest rate		8.00%
Direct debt issuance costs		$ 13,467
Offering cost attributable to equity		$ 1,398

Convertible Senior Notes Due 2023 - Schedule of Components of Net Carrying Amount of Convertible Notes (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Oct. 31, 2018	Dec. 31, 2017
Debt Instrument [Line Items]
Long-term Debt			$ 9,432
Convertible Senior Notes Due 2023
Debt Instrument [Line Items]
5.00% Convertible Senior Notes	$ 475,000	$ 475,000
Unamortized discount	(41,687)
Unamortized transaction costs	(12,946)
Long-term Debt	$ 420,367

Convertible Senior Notes Due 2023 - Schedule of Interest Expense Schedule of Interest Expense Related to Convertible Notes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Amortization of discount on convertible senior notes due 2023	$ 2,180
Total	5,669	$ 693	$ 772
Convertible Senior Notes Due 2023
Debt Instrument [Line Items]
Contractual coupon interest	5,302
Amortization of discount on convertible senior notes due 2023	2,152
Amortization of direct issue costs	28
Total	$ 7,482

Capital Stock - Additional Information (Detail)	1 Months Ended		2 Months Ended	12 Months Ended
Capital Stock - Additional Information (Detail)	Jul. 31, 2018 $ / shares shares	Feb. 28, 2018 shares	Mar. 31, 2018 $ / shares shares	Dec. 31, 2018 shares	Jul. 31, 2018 $ / shares	Mar. 31, 2018 $ / shares	Dec. 31, 2017 Vote $ / shares shares
Class of Stock [Line Items]
Capital Stock Authorized				0			1
Capital Stock Issued				0			1
Capital Stock outstanding				0			1
Capital stock, par value \| $ / shares							$ 1
Capital stock, vote entitled to each share \| Vote							1
IPO [Member] \| Underwriter Options [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues	1,350,000
Class 1 Common Stock [Member] \| Privateer Holdings [Member]
Class of Stock [Line Items]
Stock issued during period, shares, in exchange of assets		75,000,000
Class 1 Common Stock [Member] \| IPO [Member] \| Privateer Holdings [Member]
Class of Stock [Line Items]
Conversion of stock, shares converted into Class 2 common stock		58,333,333
Stock issued during period, shares, new issues		16,666,667
Class 2 Common Stock [Member] \| IPO [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues	10,350,000
Share Price \| (per share)	$ 17.00				$ 22.45
Conversion of Series A preferred stock to common stock	7,794,042
Series A preferred stock conversion basis				one-for-one basis
Class 2 Common Stock [Member] \| IPO [Member] \| Privateer Holdings [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues		58,333,333
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Stock issued during period, shares, new issues			7,794,042
Shares Issued, Price Per Share \| (per share)			$ 7.10			$ 8.90

Capital Stock - Summary of Capital Stock (Detail)	12 Months Ended
Capital Stock - Summary of Capital Stock (Detail)	Dec. 31, 2018 $ / shares shares
Class 1 Common Stock [Member]
Class of Stock [Line Items]
Common stock, par value \| $ / shares	$ 0.0001
Common stock, shares authorized \| shares	250,000,000
Common stock voting rights	10 votes for each share
Class 2 Common Stock [Member]
Class of Stock [Line Items]
Common stock, par value \| $ / shares	$ 0.0001
Common stock, shares authorized \| shares	500,000,000
Common stock voting rights	1 vote for each share
Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, par value \| $ / shares	$ 0.0001
Preferred stock, shares authorized \| shares	10,000,000
Convertible preferred stock voting rights	N/A

Capital Stock - Summary of Capital Stock (Parenthetical) (Detail)	Dec. 31, 2018 Vote
Class 1 Common Stock [Member]
Class of Stock [Line Items]
Common stock, votes for each share	10
Class 2 Common Stock [Member]
Class of Stock [Line Items]
Common stock, votes for each share	1

General and Administrative Expenses - Schedule of General and Administrative Expenses (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
General And Administrative Expense [Abstract]
Salaries	$ 11,721	$ 3,717	$ 2,640
Professional fees	7,557	1,715	424
Travel expenses	2,031	287	109
Depreciation and amortization	1,598	902	591
Other expenses	8,400	1,780	1,126
Total	$ 31,307	$ 8,401	$ 4,890

Stock-Based Compensation - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	May 21, 2018
Original Stock Option Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense	$ 359,000	$ 139,000	$ 94,000
Weighted average fair values of stock options granted, per share	$ 3.05	$ 1.79	$ 1.91
Intrinsic values of stock options exercised	$ 176,000	$ 19,000	$ 51,000
Unrecognized compensation expense	$ 557,000
Unrecognized stock-based compensation expense to be recognized in period, years	1 year 1 month 6 days
Fair values of stock option vested	$ 276,000	145,000	$ 118,000
Original Stock Option Plan [Member] \| Privateer Holdings [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares reserved for future issuance	6,760,879
Percentage of stock issuance under the plan	100.00%
Share based compensation arrangement by share based payment award vesting period from grant date	4 years
Vested options expire, if not exercised for periods from the date of grant	10 years
2018 Equity Incentive Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense	$ 20,629,000
Stock Options, Restricted Stock Units Or Restricted Stock Awards Granted		$ 0
2018 Equity Incentive Plan [Member] \| Class 2 common stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares reserved for future issuance				9,199,338
Common shares reserved for issuance, annual automatic increase percentage	4.00%
2018 Equity Incentive Plan [Member] \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation, grant term	10 years
2018 Equity Incentive Plan [Member] \| Maximum [Member] \| Class 2 common stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number Of Common Stock Reserved For Issuance Term	10 years
2018 Equity Incentive Plan [Member] \| SARs [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation, number of other than optins issued	0
2018 Equity Incentive Plan [Member] \| SARs [Member] \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation, grant term	10 years
2018 Equity Incentive Plan [Member] \| Stock Options and Restricted Stock Units [Member] \| Class 2 common stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares reserved for future issuance	12,926,172
2018 Equity Incentive Plan [Member] \| Time-based Stock Options [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average fair values of stock options granted, per share	$ 7.74
Unrecognized compensation expense	$ 38,250,000
Unrecognized stock-based compensation expense to be recognized in period, years	2 years 9 months 18 days
Fair values of stock option vested	$ 5,508,000
2018 Equity Incentive Plan [Member] \| Performance-based Stock Options [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average fair values of stock options granted, per share	$ 4.15
Unrecognized compensation expense	$ 593,000
Unrecognized stock-based compensation expense to be recognized in period, years	7 months 6 days
Fair values of stock option vested	$ 1,246,000
2018 Equity Incentive Plan [Member] \| Time-based RSU [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized stock-based compensation expense to be recognized in period, years	3 years 2 months 1 day
Share-based compensation, number of other than optins issued	237,222	0
Unrecognized stock-based compensation expense	$ 10,336,000
Number of RSUs vested	0
2018 Equity Incentive Plan [Member] \| Performance-based RSUs [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unrecognized stock-based compensation expense to be recognized in period, years	1 year 8 months 23 days
Share-based compensation, number of other than optins issued	1,050,000	0
Unrecognized stock-based compensation expense	$ 1,882,000
Number of RSUs vested	0
2018 Equity Incentive Plan [Member] \| Non-Employee Director [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock Granted Fair Value Share Based Compensation	$ 1,000,000
2018 Equity Incentive Plan [Member] \| Non-Employee Director [Member] \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock Granted Value Share Based Compensation	$ 500,000
2018 Equity Incentive Plan [Member] \| Restricted Stock Units (RSUs) [Member] \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	4 years
2018 Equity Incentive Plan [Member] \| Restricted Stock Units (RSUs) [Member] \| Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period	3 years

Stock-Based Compensation - Weighted Average Fair Value Assumptions (Detail)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Original Stock Option Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected stock option life	5 years 1 month 24 days	5 years 10 months 2 days	6 years 18 days
Expected volatility	48.82%	56.23%	63.32%
Risk-free interest rate	2.35%	2.01%	1.46%
Expected dividend yield	0.00%	0.00%	0.00%
2018 Equity Incentive Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected stock option life	5 years 9 months 14 days
Expected volatility	58.54%
Risk-free interest rate	2.92%
Expected dividend yield	0.00%

Stock-Based Compensation - Schedule of Stock Option Activity (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Original Stock Option Plan [Member]
Stock options
Shares, Beginning Balance	364,571
Shares, Granted	304,942
Shares, Exercised	(45,688)
Shares, Forfeited	(25,881)
Shares, Cancelled	(5,350)
Shares, Ending Balance	592,594	364,571
Shares, Vested and expected to vest	522,301
Shares, Vested and exercisable	286,393
Weighted-average exercise price
Weighted-average exercise price, Beginning Balance	$ 2.41
Weighted-average exercise price, Granted	5.92
Weighted-average exercise price, Exercised	1.81
Weighted-average exercise price, Forfeited	5.14
Weighted-average exercise price, Cancelled	3.29
Weighted-average exercise price, Ending Balance	4.14	$ 2.41
Weighted-average exercise price, Vested and expected to vest	3.94
Weighted-average exercise price, Vested and exercisable	$ 2.85
Weighted-average remaining contractual term (years)
Weighted-average remaining contractual term	8 years 1 month 6 days	7 years 10 months 24 days
Weighted-average remaining contractual term, Vested and expected to vest	8 years
Weighted-average remaining contractual term, Vested and exercisable	7 years 2 months 12 days
Aggregate intrinsic value
Aggregate intrinsic value	$ 989	$ 1,185
Aggregate intrinsic value, Vested and expected to vest	955
Aggregate intrinsic value, Vested and exercisable	$ 805
2018 Equity Incentive Plan [Member] \| Time-based Stock Options [Member]
Stock options
Shares, Beginning Balance	0
Shares, Granted	6,106,011
Shares, Exercised
Shares, Forfeited	(90,970)
Shares, Cancelled
Shares, Ending Balance	6,015,041	0
Shares, Vested and expected to vest	5,708,817
Shares, Vested and exercisable	1,312,500
Weighted-average exercise price
Weighted-average exercise price, Beginning Balance	$ 0
Weighted-average exercise price, Granted	13.66
Weighted-average exercise price, Exercised
Weighted-average exercise price, Forfeited	21.49
Weighted-average exercise price, Cancelled
Weighted-average exercise price, Ending Balance	13.54	$ 0
Weighted-average exercise price, Vested and expected to vest	13.54
Weighted-average exercise price, Vested and exercisable	$ 7.76
Weighted-average remaining contractual term (years)
Weighted-average remaining contractual term	7 years 8 months 12 days
Weighted-average remaining contractual term, Vested and expected to vest	9 years 4 months 24 days
Weighted-average remaining contractual term, Vested and exercisable	9 years 4 months 24 days
Aggregate intrinsic value
Aggregate intrinsic value	$ 342,916
Aggregate intrinsic value, Vested and expected to vest	326,567
Aggregate intrinsic value, Vested and exercisable	$ 82,399
2018 Equity Incentive Plan [Member] \| Performance-based Stock Options [Member]
Stock options
Shares, Beginning Balance	0
Shares, Granted	600,000
Shares, Ending Balance	600,000	0
Shares, Vested and expected to vest	591,486
Shares, Vested and exercisable	300,000
Weighted-average exercise price
Weighted-average exercise price, Beginning Balance	$ 0
Weighted-average exercise price, Granted	7.76
Weighted-average exercise price, Ending Balance	7.76	$ 0
Weighted-average exercise price, Vested and expected to vest	7.76
Weighted-average exercise price, Vested and exercisable	$ 7.76
Weighted-average remaining contractual term (years)
Weighted-average remaining contractual term	9 years 4 months 24 days
Weighted-average remaining contractual term, Vested and expected to vest	9 years 4 months 24 days
Weighted-average remaining contractual term, Vested and exercisable	9 years 4 months 24 days
Aggregate intrinsic value
Aggregate intrinsic value	$ 37,668	$ 0
Aggregate intrinsic value, Vested and expected to vest	37,134
Aggregate intrinsic value, Vested and exercisable	$ 18,834

Stock-Based Compensation - Schedule of RSU Activity (Detail) - 2018 Equity Incentive Plan [Member]	12 Months Ended
	Dec. 31, 2018 $ / shares shares
Time-based RSU [Member]
Share equivalent
Share equivalent, Beginning Balance \| shares	0
Share equivalent, Granted \| shares	238,082
Share equivalent, Exercised \| shares	0
Share equivalent, Forfeited \| shares	(860)
Share equivalent, Ending Balance \| shares	237,222
Weighted-average grant date fair value
Weighted-average grant date fair value, Beginning Balance \| $ / shares	$ 0
Weighted-average grant date fair value, Granted \| $ / shares	50.08
Weighted-average grant date fair value, Exercised \| $ / shares	0
Weighted-average grant date fair value, Forfeited \| $ / shares	110
Weighted-average grant date fair value, Ending Balance \| $ / shares	$ 49.86
Performance-based RSUs [Member]
Share equivalent
Share equivalent, Beginning Balance \| shares	0
Share equivalent, Granted \| shares	1,050,000
Share equivalent, Exercised \| shares	0
Share equivalent, Forfeited \| shares	0
Share equivalent, Ending Balance \| shares	1,050,000
Weighted-average grant date fair value
Weighted-average grant date fair value, Beginning Balance \| $ / shares	$ 0
Weighted-average grant date fair value, Granted \| $ / shares	7.76
Weighted-average grant date fair value, Exercised \| $ / shares	0
Weighted-average grant date fair value, Forfeited \| $ / shares	0
Weighted-average grant date fair value, Ending Balance \| $ / shares	$ 7.76

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Operating Loss Carryforwards [Line Items]
Equity portion of convertible notes	$ 8,471
Deferred income tax recovery	$ 4,485
United States statutory income tax rate	21.00%	35.00%
Accumulated tax losses available to offset future years’ federal and provincial taxable income	$ 51,064	$ 30,000
Operating Loss Carryforwards	51,064
Deferred Tax Asset, Valuation Allowance [Member]
Operating Loss Carryforwards [Line Items]
Increase in deferred tax valuation allowance	5,832	2,765
Valuation allowance increase due to current year losses tax credit foreign exchange and other	10,317
Australian [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	162	167
Portuguese [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	$ 2,538	$ 74
Net operating loss carryforward expiration year	2023
Net operating loss carryforward expiration period	5 years
U.S. [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	$ 19,872
Net operating loss carryforwards offset percentage of taxable income.	80.00%
Alef [Member]
Operating Loss Carryforwards [Line Items]
Deferred tax liability from purchase price allocation	$ 100
Convertible Senior Notes Due 2023
Operating Loss Carryforwards [Line Items]
Equity portion of convertible notes	$ 8,809

Income Taxes - Loss Loss Before Income Taxes (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Canada	$ (25,333)	$ (7,411)	$ (7,883)
Loss before income taxes	(72,174)	(7,809)	$ (7,883)
U.S. [Member]
Other countries	(42,418)
Portugal [Member]
Other countries	(2,208)
Other Countries [Member]
Other countries	$ (2,215)	$ (398)

Income Taxes - Summary of Expense for Income Taxes (Detail) $ in Thousands	12 Months Ended
	Dec. 31, 2018 USD ($)
Current:
Other countries	$ 34
Total	34
Deferred:
U.S.	(4,485)
Total	$ (4,485)

Income Taxes - Summary of Effective Income Tax Rate Reconciliation (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Income Tax Disclosure [Abstract]
Loss before income taxes:	$ (72,174)	$ (7,809)	$ (7,883)
Expected income tax recovery	(15,157)	(2,733)	(2,797)
Difference in foreign tax rates	(1,864)	675	719
Foreign exchange and other	1,399	(480)	(72)
Non-deductible expenses	5,331	61	(40)
Changes in enacted rates		(288)
Utilization of losses no previously recognized		(9)
Change in valuation allowance	5,840	$ 2,774	$ 2,190
Income tax recovery, net	$ (4,451)

Income Taxes - Summary of Components of Deferred Tax (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Deferred assets
Tax loss carryforwards – Canada	$ 13,723	$ 8,297	$ 5,821
Property and equipment	2,510	183	98
Deferred financing costs	27	37
Investment tax credits and related pool balance	57	57	57
Other		8
Total Deferred tax assets	21,097	8,730	5,985
Less valuation allowance	(14,433)	(8,601)	(5,836)
Net deferred tax assets	6,664	129	149
Deferred tax liabilities
Plant and equipment	(2,328)
Intangible assets	(289)	(129)	(144)
Deferred financing costs			(5)
Equity portion of convertible senior notes due 2023	(8,471)
Total deferred tax liabilities	(11,088)	(129)	(149)
Net deferred tax liability	(4,424)
U.S. [Member]
Deferred assets
Tax loss carryforwards	4,173
Other Countries [Member]
Deferred assets
Tax loss carryforwards	$ 607	$ 148	$ 9

Income Taxes - Summary of Canadian Non-Capital Loss Carryforwards (Detail) $ in Thousands	Dec. 31, 2018 USD ($)
Operating Loss Carryforwards [Line Items]
Non-capital loss carryforwards	$ 51,064
2033 [Member]
Operating Loss Carryforwards [Line Items]
Non-capital loss carryforwards	381
2034 [Member]
Operating Loss Carryforwards [Line Items]
Non-capital loss carryforwards	6,429
2035 [Member]
Operating Loss Carryforwards [Line Items]
Non-capital loss carryforwards	7,627
2036 [Member]
Operating Loss Carryforwards [Line Items]
Non-capital loss carryforwards	7,230
2037 [Member]
Operating Loss Carryforwards [Line Items]
Non-capital loss carryforwards	6,195
2038 [Member]
Operating Loss Carryforwards [Line Items]
Non-capital loss carryforwards	$ 23,202

Income Taxes - Summary of Open Tax Years (Detail)	12 Months Ended
Income Taxes - Summary of Open Tax Years (Detail)	Dec. 31, 2018
Portugal [Member] \| Minimum [Member]
Income Tax Examination [Line Items]
Open Years	2017
Portugal [Member] \| Maximum [Member]
Income Tax Examination [Line Items]
Open Years	2018
Netherlands [Member] \| Minimum [Member]
Income Tax Examination [Line Items]
Open Years	2016
Netherlands [Member] \| Maximum [Member]
Income Tax Examination [Line Items]
Open Years	2018
Canada [Member] \| Minimum [Member]
Income Tax Examination [Line Items]
Open Years	2014
Canada [Member] \| Maximum [Member]
Income Tax Examination [Line Items]
Open Years	2018
Germany [Member] \| Minimum [Member]
Income Tax Examination [Line Items]
Open Years	2016
Germany [Member] \| Maximum [Member]
Income Tax Examination [Line Items]
Open Years	2018
Australia [Member] \| Minimum [Member]
Income Tax Examination [Line Items]
Open Years	2017
Australia [Member] \| Maximum [Member]
Income Tax Examination [Line Items]
Open Years	2018

Income Taxes - Summary of Movements in Valuation Allowance (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Income Tax Disclosure [Abstract]
Balance at beginning of year	$ 8,601	$ 5,836
Change due to expense and foreign exchange	(113)	395
Deductions	5,945	2,370
Balance at end of year	$ 14,433	$ 8,601

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Long Term Purchase Commitment [Line Items]
Lease expiration date	Sep. 30, 2027
Rent expense under operating leases	$ 745	$ 175	$ 0
Rose Lifescience, Inc [Member] \| Distribution and Marketing [Member]
Long Term Purchase Commitment [Line Items]
Minimum commitment Fees	$ 500
Commitment Term	5 years

Commitments and Contingencies - Schedule of Future Minimum Rental Payments Under All Non-cancelable Capital and Operating Leases (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Operating leases future minimum payments
2019	$ 916	$ 46
2020	857	15
2021	727
2022	589
2023	510
Thereafter	1,372
Total	4,971	61
Capital leases future minimum payments
2019	733	772
2020	733	772
2021	733	772
2022	733	772
2023	183	579
Total	$ 3,115	$ 3,667

Acquisitions - Additional Information (Detail) - Alef [Member] $ in Thousands	1 Months Ended
	Oct. 31, 2018 USD ($)
Business Acquisition [Line Items]
Total consideration transferred	$ 2,893
Consideration held in escrow	736
Cash consideration	38
Alef License [Member]
Business Acquisition [Line Items]
Recognized intangible asset	2,984
Class 2 Common Stock [Member]
Business Acquisition [Line Items]
Consideration transferred in stock	$ 2,855

Financial Instruments - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Financial Instruments [Abstract]
Change in exchange rate	10.00%
Carrying value of net asset	$ 2,817
Foreign exchange loss (gain), net	$ 7,234	$ (1,363)	$ (186)

Related Party Transactions - Summary of Various Components of Parent Company Debt Facilities Represents Related Party Balances Outstanding (Detail) $ in Thousands	Dec. 31, 2017 USD ($)
Related Party Transaction [Line Items]
Total	$ 32,826
Privateer Holdings [Member]
Related Party Transaction [Line Items]
Total	32,826
Privateer Holdings Credit Facility [Member] \| Privateer Holdings [Member]
Related Party Transaction [Line Items]
Total	24,700
Privateer Holdings Construction Facility [Member] \| Privateer Holdings [Member]
Related Party Transaction [Line Items]
Total	6,395
Privateer Holdings Start Up Loans [Member]
Related Party Transaction [Line Items]
Total	1,731
Privateer Holdings Start Up Loans [Member] \| Privateer Holdings [Member]
Related Party Transaction [Line Items]
Total	$ 1,731

Related Party Transactions - Additional Information (Detail) - USD ($) $ in Thousands			1 Months Ended	12 Months Ended
	Apr. 01, 2018	Jan. 01, 2018	Jul. 31, 2018	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 01, 2017	Nov. 01, 2017	Jan. 01, 2016
Related Party Transaction [Line Items]
Repayment under Privateer Holdings debt facilities				$ 36,940
Privateer Holdings [Member]
Related Party Transaction [Line Items]
Interest expense				567	$ 548	$ 992
Repayment under Privateer Holdings debt facilities			$ 36,940	$ 3,878	$ 3,397
Business development and research and development services mark up percentage				9.00%
Personnel compensation mark up percentage				3.00%
Management service fees floating interest rate				2.54%
Privateer Holdings [Member] \| Revolving Credit Facility [Member]
Related Party Transaction [Line Items]
Line of credit facility, maximum borrowing capacity	$ 7,000								$ 25,000
Line of credit facility, interest rate	2.62%				2.54%
Privateer Holdings [Member] \| Demand Revolving Construction Facility [Member] \| High Park Farms Ltd [Member]
Related Party Transaction [Line Items]
Line of credit facility, maximum borrowing capacity								$ 10,000
Line of credit facility, interest rate		2.54%
Privateer Holdings [Member] \| Demand Construction Facility [Member] \| Tilray Canada, Ltd. [Member]
Related Party Transaction [Line Items]
Line of credit facility, maximum borrowing capacity							$ 1,000
Line of credit facility, interest rate		2.54%

Related Party Transactions - Summary of Outstanding Balances under Loans (Detail) $ in Thousands	Dec. 31, 2017 USD ($)
Related Party Transaction [Line Items]
Due to related parties, current	$ 32,826
Privateer Holdings Start Up Loans [Member]
Related Party Transaction [Line Items]
Due to related parties, current	1,731
Tilray Deutschland GmbH [Member] \| Privateer Holdings Start Up Loans [Member]
Related Party Transaction [Line Items]
Due to related parties, current	1,340
Tilray Portugal Unipessoal Lda [Member] \| Privateer Holdings Start Up Loans [Member]
Related Party Transaction [Line Items]
Due to related parties, current	105
Other [Member] \| Privateer Holdings Start Up Loans [Member]
Related Party Transaction [Line Items]
Due to related parties, current	$ 286

Business Segment Information - Additional Information (Detail) - Segment	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Number of operating segment	1
Customer Concentration Risk [Member] \| Revenue [Member] \| Customer A [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	24.00%
Customer Concentration Risk [Member] \| Revenue [Member] \| Minimum [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	10.00%
Customer Concentration Risk [Member] \| Revenue [Member] \| Minimum [Member] \| No Customer [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage		10.00%	10.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer A [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	16.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer B [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	30.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Minimum [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage	10.00%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Minimum [Member] \| No Customer [Member]
Segment Reporting Information [Line Items]
Concentration risk percentage		10.00%

Business Segment Information - Summary of Sources of Revenue (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Revenues	$ 15,531	$ 10,047	$ 9,744	$ 7,808	$ 5,113	$ 5,406	$ 4,992	$ 5,027	$ 43,130	$ 20,538	$ 12,644
Dried Cannabis [Member]
Segment Reporting Information [Line Items]
Revenues									21,674	16,260	11,324
Cannabis Extracts [Member]
Segment Reporting Information [Line Items]
Revenues									21,179	3,965	1,107
Accessories and other [Member]
Segment Reporting Information [Line Items]
Revenues									$ 277	$ 313	$ 213

Business Segment Information - Summary of Revenues Attributed to a Geographic Region Based on the Location of the Customer (Detail) - USD ($) $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Segment Reporting Information [Line Items]
Revenues	$ 15,531	$ 10,047	$ 9,744	$ 7,808	$ 5,113	$ 5,406	$ 4,992	$ 5,027	$ 43,130	$ 20,538	$ 12,644
CANADA [Member]
Segment Reporting Information [Line Items]
Revenues									40,209	19,775	$ 12,644
Other Countries [Member]
Segment Reporting Information [Line Items]
Revenues									$ 2,921	$ 763

Business Segment Information - Summary of Long-lived Assets Consisting of Property, Plant and Equipment, Net of Accumulated Depreciation, Attributed to Geographic Regions Based On Their Physical Location (Detail) - USD ($) $ in Thousands	Dec. 31, 2018	Dec. 31, 2017
Segment Reporting Information [Line Items]
Property, plant and equipment, net	$ 80,214	$ 39,985
CANADA [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment, net	64,687	39,086
Portugal [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment, net	15,455
Other Countries [Member]
Segment Reporting Information [Line Items]
Property, plant and equipment, net	$ 72	$ 899

Schedule of Quarterly Financial Data (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended								12 Months Ended
	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Quarterly Financial Information Disclosure [Abstract]
Revenue	$ 15,531	$ 10,047	$ 9,744	$ 7,808	$ 5,113	$ 5,406	$ 4,992	$ 5,027	$ 43,130	$ 20,538	$ 12,644
Gross Margin	3,134	3,068	4,177	3,896	2,934	2,967	2,708	2,768	14,275	11,377	2,670
Operating Loss	(22,908)	(20,012)	(10,990)	(3,740)	(2,612)	(2,182)	(2,316)	(388)	(57,650)	(7,498)	(7,049)
Net loss	$ (31,010)	$ (18,699)	$ (12,833)	$ (5,181)	$ (2,928)	$ (1,767)	$ (2,435)	$ (679)	$ (67,723)	$ (7,809)	$ (7,883)
Net loss per share - basic and diluted	$ (0.33)	$ (0.21)	$ (0.17)	$ (0.07)	$ (0.04)	$ (0.02)	$ (0.01)	$ (0.01)	$ (0.82)	$ (0.10)	$ (0.11)

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References + Details

Subsequent Events - Additional Information (Detail) - Subsequent Event [Member] $ in Thousands, $ in Thousands	1 Months Ended
	Feb. 28, 2019 USD ($) Store	Feb. 28, 2019 CAD ($) Store
FHF Holdings Ltd. [Member]
Subsequent Event [Line Items]
Total consideration transferred	$ 319,000	$ 419,000
Number of stores	16,000	16,000
Natura Naturals Holdings Inc. [Member]
Subsequent Event [Line Items]
Total consideration transferred	$ 53,400	$ 70,000